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SUMMARY 
Many gaps remain in our current state of knowledge about 
the epidemiology, phenomenology, neurobiology, and 
psychopharmacology of posttraumatic stress disorder (PTSD) 
in children and adolescents. Empirical evidence, 
particularly in non-Western settings, is sparse and there 
is little convergent understanding of the inter-
relationship of epidemiological factors, PTSD symptom 
expression, full and partial syndromes, disorders comorbid 
with PTSD, and pharmacotherapeutic interventions. 
Clinicians are faced with the difficult task of treating 
this often complicated and debilitating disorder in youth 
in the absence of data from well-controlled clinical 
trials. The studies detailed here are a point of departure 
for understanding the confluence that exists between 
epidemiological, phenomenological, and pharmacotherapeutic 
aspects of adolescent PTSD. Two studies were conducted to 
investigate the prevalence and effects of violence exposure 
and PTSD, clinical and functional correlates of full and 
partial syndromes, and associated gender differences in 
school and clinic samples, respectively. Two preliminary 
open-label trials assessed the efficacy and safety of a 
selective serotonin reuptake inhibitor (SSRI) in 
adolescents with at least moderate severity PTSD. 
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The results indicate that (i) partial PTSD is a common 
nosological entity in adolescents, (ii) gender-related 
differences in PTSD, even if not manifest in differences in 
prevalence (i.e., in the rates of trauma exposure and full 
and partial PTSD), may well manifest in symptom expression 
(i.e., higher symptom burden in girls), associated 
morbidity, and functional impairment, and (iii) SSRIs may 
be effective in treating core PTSD symptoms in this age 
group.  
 
While not yet demonstrated, the partial subtype may have 
similar biological underpinnings to full PTSD in 
adolescents and may benefit from similar 
pharmacotherapeutic interventions. This is an area 
deserving of further investigation. Controlled SSRI data 
are needed to establish if these should be agents of choice 
for paediatric PTSD. 
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OPSOMMING 
Daar is tans nog baie leemtes in ons kennis oor die 
epidemiologie, fenomenologie, neurobiologie en 
psigofarmakologie van post-traumatiese stressteuring (PTSS) 
in kinders en adolessente. Empiriese bewys, in die besonder 
in nie-Westerse omgewings, is yl gesaai en daar is min 
ooreenstemming wat betref begrip van die onderlinge 
verwantskap van epidemiologiese faktore, uitdrukking van 
PTSS-simptome, volledige en gedeeltelike sindrome, 
ongesteldhede wat komorbied tesame met PTSS voorkom, en 
farmakoterapeutiese intervensies. Klinici kom te staan voor 
die moeilike taak om hierdie dikwels gekompliseerde en 
uitmergelende ongesteldheid in jongmense te behandel 
ondanks die afwesigheid van data na aanleiding van goed 
gekontroleerde kliniese studies. Die studies wat hier 
opgesom word, is ’n vertrekpunt onderweg na begrip van die 
samesmelting tussen epidemiologiese, fenomenologiese, en 
farmakoterapeutiese aspekte van PTSS by adolessente. Twee 
studies is uitgevoer om die voorkoms en gevolge van 
blootstelling aan geweld en PTSS, kliniese en funksionele 
korrelate van volledige en gedeeltelike sindrome, en 
daarmee gepaardgaande geslagsverskille in skool- en 
klinieksteekproewe onderskeidelik te ondersoek. Twee 
voorlopige oop (‘open-label’) studies het die 
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doeltreffendheid en veiligheid van ’n selektiewe serotonien 
heropname-inhibeerder (SSHI) in adolessente met ten minste 
matig ernstige PTSS geassesseer. 
 
Die resultate dui daarop dat (i) gedeeltelike PTSS ’n 
algemene nosologiese entiteit in adolessente is, (ii) 
geslagsverwante verskille in PTSS, selfs al is dit nie 
sigbaar in verskille ten opsigte van voorkoms nie (m.a.w. 
in die koers van blootstelling aan trauma en volledige en 
gedeeltelike PTSS), wel in die uitdrukking van simptome 
(m.a.w. ’n hoër simptoomlading in dogters), gepaardgaande 
morbiditeit en funksionele inkorting kan manifesteer, en 
(iii) SSHI’s doeltreffend kan wees in die behandeling van 
kern- PTSS-simptome in hierdie ouderdomsgroep.  
 
Alhoewel dit nog nie aangetoon is nie, kan die gedeeltelike 
subtipe soortgelyke biologiese onderstutting as die 
volledige PTSS in adolessente hê en dit kan dus by 
soortgelyke farmakoterapeutiese intervensies baat. Hierdie 
veld bied geleentheid vir verdere ondersoek. Gekontroleerde 
SSHI-data is nodig om vas te stel of dit die middels van 
keuse by pediatriese PTSS behoort te wees. 
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1. INTRODUCTION: POSTTRAUMATIC STRESS DISORDER IN CHILDREN  
   AND ADOLESCENTS  
 
1.1 Epidemiology and Aetiology 
Exposure to high-magnitude trauma occurs at alarmingly high 
rates in children and adolescents. Community studies in 
adolescents and young adults have documented trauma 
exposure rates (DSM-III R) ranging from 39% to 84% (Breslau 
et al., 1991; Vrana and Lauterbach, 1994). For example, in 
a community epidemiological study of adolescents, 43% had 
experienced at least one DSM-IIIR trauma by the age of 
eighteen and posttraumatic stress disorder (PTSD) was 
evident in 14,5% of adolescents who were exposed (Giaconia 
et al., 1995). In contrast, studies of at-risk children and 
adolescents (i.e., trauma-exposed) have reported PTSD 
prevalence rates of up to 100% (Frederick, 1985; Garrison 
et al., 1995; Perkonigg et al., 2000). Notably, events that 
may be reported as particularly upsetting are not always 
the most likely to lead to PTSD.  
 
Rates for the development of PTSD in children and 
adolescents also vary widely according to the type of 
exposure (Kessler et al., 1995; Breslau et al., 1998). 
Interpersonal, high-intensity traumas, such as rape or 
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other types of sexual assault, are associated with the 
highest rates of PTSD, while exposure to natural disasters 
(such as floods and fires) are associated with much lower 
rates of the disorder (Yehuda, 2002). 
 
While it is widely recognised that PTSD is more common in 
youth exposed to ‘external’, high magnitude life-
threatening events, such as criminal assault (Pynoos et 
al., 1987), severe burns (Stoddard et al., 1989), 
hospitalisation following accidental injury (Daviss et al., 
2000), motor vehicle accidents (Stallard et al., 2004), 
combat/war (Clarke et al., 1993; Durakovic-Belko et al., 
2003), hostage taking (Schwarz and Kowalski, 1991), man-
made disasters (March et al., 1997; Fremont, 2004, review) 
and natural disasters (Burke et al., 1986; Lee et al., 
2004; Groome and Soureti, 2004); prevalence rates indicate 
that not all trauma-exposed children and adolescents 
develop PTSD. Factors such as severity of trauma exposure, 
duration of exposure, physical and emotional proximity, 
individual patient characteristics, and parental factors 
may influence the development of PTSD in children and 
adolescents (Silva et al., 2000; Foy et al., 1996, 
Pfefferbaum, 1997). Severity of trauma exposure and 
parental trauma-related distress have consistently produced 
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positive correlations with PTSD symptoms, while the length 
of time since trauma exposure in consistently negatively 
correlated with PTSD severity in this age group (Foy et 
al., 1996). Both the aforementioned findings are compatible 
with findings for adults (Foy et al., 1996). As is common 
with other psychiatric disorders, gender effects in 
exposure to trauma and PTSD have also been documented. For 
example, in an epidemiological sample (N=2,311) of young 
people who were recruited as participants at entry into 
first grade and then interviewed about a history of trauma 
and PTSD when their mean age was 21 years (Breslau et al., 
2004) the lifetime occurrence of assaultive violence was 
significantly higher in males than females (62.6% vs. 
33.7%), however females had higher rates of PTSD than males 
following assaultive violence (odds ratio of 4). 
Interestingly, gender differences in the rate of PTSD 
following other traumas were not observed. Thus, findings 
of higher rates of trauma exposure overall in boys, with 
higher rates of PTSD in girls (Cuffe et al., 1999; Giaconia 
et al., 1995; Breslau et al., 1997) have not been 
conclusive across all studies. Furthermore, many studies 
have not controlled for possible differences in lifetime 
trauma exposure between boys and girls.  
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Identification of etiological mechanisms and risk factors 
for development of the disorder has been an important 
recent thrust in PTSD research. Currently, it is viewed a 
complex disorder that is multifactorially mediated by 
biological dysregulation of noradrenergic, serotonergic, 
glutamatergic, dopaminergic, opioid and neuroendocrine 
pathways (among others) (Friedman and Southwick, 1995). In 
addition to neurobiological disturbances, etiological 
theories of PTSD have identified cognitive and behavioural 
factors as being contributory. Current evidence indicates 
that traumatized children, like traumatized adults, 
demonstrate altered hypothalamic-pituitary-adrenal (HPA) 
axis circadian rhythmicity, although there is little 
consensus on whether cortisol levels are elevated, reduced, 
or remain unchanged in paediatric PTSD. For example, a 
recent adolescent study did not find evidence for enhanced 
suppression of morning cortisol in multiply traumatized 
adolescents with or without PTSD (Lipschitz et al., 2003). 
In adults, recent data suggest that low cortisol levels may 
be an early predictor rather than a consequence of the 
disorder. For example, in a study examining cortisol 
responses in the acute aftermath of rape, low cortisol was 
associated with a prior rape or assault but not with the 
development of PTSD per se (Resnick et al., 1995). These 
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findings have not yet been replicated in children and 
adolescents.  
 
Neuroimaging studies in posttraumatic stress disorder 
(PTSD) have also been largely restricted to adult 
populations. Structural and functional studies implicate 
the amygdala, hippocampus, anterior cingulate, Broca’s 
area, medial prefrontal cortex, and visual cortex (Pitman 
et al., 2001, review). One published study to date assessed 
these neural correlates in adolescents (Yang et al., 2004).  
Brain activation was measured by functional magnetic 
resonance imaging during visual perception and imagery 
recall of an earthquake in adolescent earthquake survivors 
14 months after the event. During earthquake imagery, the 
PTSD group showed activation in a number of limbic-
paralimbic and visual regions, while the control group did 
not, generally consistent with findings in adults with 
PTSD.  
 
Structural imaging studies that have specifically assessed 
the effects of childhood trauma and PTSD on brain volumes 
are, similarly, limited. De Bellis et al. (1999) found no 
evidence of reduced hippocampal or pituitary volumes 
(Thomas and De Bellis, 2004) in children with maltreatment-
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related PTSD, but did demonstrate smaller intracranial, 
whole brain and corpus callosal volumes, which may suggest 
that PTSD has an impact on global brain development. In a 
follow-up analysis, controlling for socio-economic status 
(De Bellis et al., 2002), the authors found that brain 
volumes were positively correlated with the age of onset of 
PTSD but were negatively correlated with the duration of 
abuse. Debate continues on whether reduced hippocampal 
volumes predate or follow the development of PTSD, and to 
what extent this might predict the response to trauma. 
However, the findings of a recent study in twin-pairs 
discordant for trauma exposure and PTSD suggest that lower 
pre-existing hippocampal volumes may, in fact, predispose 
individuals to developing PTSD after trauma (Gilbertson et 
al., 2002). 
 
Cognitive-behavioural theories have highlighted the 
involvement of information-processing and learning in the 
development of PTSD. Foa and colleagues (1989) have 
suggested that, following a trauma, a fear network that 
stores information about sources of threat is formed, and 
that these trauma-related representations are activated by 
external and internal cues. In children and adolescents 
with PTSD, this fear structure includes an especially large 
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number of stimuli elements and is therefore easily 
accessed. Similarly, it has been proposed (Keane et al., 
1985) that PTSD fear responses develop through a process of 
classical conditioning, whereby fear comes to be associated 
with cues present during the actual trauma (e.g., gunfire), 
as well as through a process of stimulus generalization, 
whereby any stimulus associated with these cues (e.g., a 
car backfiring or a firecracker exploding) then produces a 
fear response. Continued avoidance of traumatic cues 
reinforces the fear response, which has no opportunity to 
be ‘un-learned’. In children and adolescents, subjective 
cognitive appraisals of traumatic events vary with the 
developmental level of the child, as does the way in which 
traumatic memories are encoded and recalled (Pynoos et al., 
1996).  
 
In summary, while much remains to be understood about the 
role of developmental, neurobiological, cognitive and other 
mechanisms that may create a vulnerability to PTSD, it is 
indisputable that the disorder poses significant challenges 
to the healthy physical, cognitive and emotional 
development of children and adolescents (Giaconia et al., 
1995). 
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1.2 Phenomenology 
The hallmark features of PTSD include a history of exposure 
to an index event that threatens the life or physical 
integrity of the child or others, induces a response of 
intense fear, helplessness, or horror, and temporally 
results in the development of symptoms from each of three 
symptom clusters: re-experiencing of the trauma, avoidance 
and numbing, and hyperarousal (APA, 2000). In children and 
adolescents, re-experiencing symptoms may involve recurrent 
frightening dreams or re-enactment of traumatic themes in 
play. Avoiding thoughts, feelings, or memories of the 
trauma, restriction of affect, and markedly diminished 
interest in activities may characterise avoidance and 
numbing, while symptoms of irritability, sleep 
dysregulation, anger outbursts and concentration 
difficulties are features of hyperarousal (AACAP, 1998). To 
make a diagnosis of PTSD, symptoms must cause significant 
distress and/ or functional impairment and persist for 
longer than one month. The disorder runs a longitudinal 
course, with progressive modification of symptoms occurring 
over time (Blank, 1993; McFarlane, 2000).  
 
Partial symptomatology is not uncommon in children and 
adolescents and recent findings support the hypothesis that 
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children with subthreshold criteria may not differ 
significantly from children meeting all three cluster 
criteria (re-experiencing, avoidance, hyperarousal) with 
regard to functional impairment and distress. For example, 
in a study by Carrion and colleagues (2002), children with 
subthreshold PTSD had functional impairment that was 
specific to PTSD symptoms and was not due to comorbidity. 
This suggests that it might be more precise to make a 
diagnosis of PTSD in children and adolescents based on the 
intensity of symptoms and their relationship to functional 
impairment, than on the threshold number of symptoms.  
 
While the applicability of DSM-IV nosological criteria to 
very young children is controversial, particularly as 
symptoms are often heterogeneous and developmentally-
determined (Perry, 1994; Weisenberg et al., 1993; Nader et 
al., 1990), it does provide a useful framework for guiding 
the assessment and treatment of PTSD in older children and 
adolescents (AACAP, 1998; Perrin et al., 2000). Certainly, 
the frequency and severity of symptoms in the three symptom 
clusters constitute a primary target for pharmacotherapy. 
Important differences in clinical presentation may exist 
between acute (duration of symptoms less than 3 months) and 
chronic (duration of symptoms 3 months or more) subtypes in 
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children. Famularo et al. (1996), for example, described 
prominent re-experiencing, hyperarousal, and sleep 
difficulties in the acute subtype, and detachment, 
restricted affect, dissociation, and depressed mood in the 
chronic subtype. In addition, Terr (1991) has proposed a 
two-tiered classification of childhood traumas and their 
symptom subtypes: Type I (single-incident, sudden trauma, 
characterised by detailed memories and misperceptions) and 
Type II (chronic, recurrent, usually childhood physical 
and/or sexual abuse, characterised by denial/ numbing/ 
dissociation/ rage). These subtypes may be mediated by 
different psychobiological factors, and may require 
different treatment approaches (Donnelly et al., 1999). For 
example, symptom targets in patients with more chronic PTSD 
may, in addition to the core symptom clusters, need to 
include symptoms such as guilt and shame. Also, medications 
that theoretically decrease the ability of patients to 
respond to psychotherapeutic interventions aimed at 
resolving these issues (Risse et al., 1990; Gelpin et al., 
1996) may be relatively contraindicated.   
  
Childhood PTSD precedes, predisposes to, and co-occurs with 
other psychiatric disorders. While studies investigating 
the time-sequencing of PTSD and comorbid conditions have 
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yielded conflicting results, the high rates of comorbidity 
with mood, anxiety, and substance use disorders are 
comparable with adults and can significantly impact on 
prevention and treatment (Goenjian et al., 1995; Hubbard et 
al., 1995; Yehuda and McFarlane 1995; Brady, 1997; Kessler 
et al., 1995; Giaconia et al., 1995; McCloskey and Walker, 
2000). Children with comorbid disorders (e.g., mood or 
anxiety disorders) will require interventions with broad-
spectrum effects. In addition, certain medications (e.g. 
benzodiazepines) may be relatively contraindicated for 
patients with comorbid substance use disorders. 
Furthermore, children with PTSD have been shown to have 
more behavioral-emotional problems, interpersonal problems, 
academic failure, suicidal behavior, and health problems, 
than those without PTSD (Giaconia et al., 1995; Schwab-
Stone et al., 1999, Mazza, 2000).  
 
To date, a number of DSM-IV (APA, 1994) based child-
adolescent structured interviews have been constructed to 
assist in diagnosis. At present, no ‘gold standard’ 
instrument exists. However, several reliable and valid 
assessment instruments are available to aid diagnosis, and 
a combination of both structured and unstructured child-
adolescent and caregiver interviews is recommended (AACAP, 
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1998). Structured psychiatric interviews for children, such 
as the Schedule for Affective Disorders and Schizophrenia 
for School Age Children Present and Lifetime Version (K-
SADS-PL) (Kaufman et al., 1997), the Diagnostic Interview 
Schedule for Children-Version IV (DISC-IV) (Shaffer et al., 
2000), and the Diagnostic Interview for Children and 
Adolescents (DICA) (Reich et al., 1991) contain a PTSD 
module. These instruments also assess disorders that that 
are frequently comorbid with PTSD (e.g., depressive 
disorders, anxiety disorders, substance use disorders, 
disruptive behaviour disorders). PTSD-specific interviews 
include the Clinician-Administered PTSD Scale-Child and 
Adolescent Version (CAPS-CA) (Nader et al., 1996), the 
Child PTSD Checklist (Newman and Amaya-Jackson, 1996), and 
the Child PTSD Symptom Scale (Foa et al., 2001). Finally, a 
number of scales are available for assessing the severity 
of PTSD symptoms in children, such as the Child Post-
Traumatic Stress Reaction Index (Nader et al., 1993), the 
Child and Adolescent Trauma Survey (March, 1999) and the 
Trauma Symptom Checklist for Children (Briere, 1996). 
Direct reports from parents, teachers and other observers 
in the child’s milieu are an important component of 
evaluation, although it should be borne in mind that 
parents often minimize a child’s symptomatology (AACAP, 
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1998). Thus, the use of multiple assessment instruments and 
multiple informants to measure PTSD across different areas 
of functioning, is recommended. That said, nothing can 
replace a properly conducted and comprehensive clinical 
interview. 
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1.3 Pharmacotherapy  
Despite better insights into the pathophysiology of PTSD 
and other anxiety disorders and compelling evidence that a 
number of key psychobiological systems are dysregulated, 
there is a relative dearth of rigorously designed 
pharmacotherapy trials for childhood anxiety disorders 
(March et al., 1996; Donnelly et al., 1999). Biological 
research in the field has been impeded by a plethora of 
ethical considerations peculiar to this population, for 
e.g., developmental immaturity, risks posed by treatment, 
and problems associated with ‘informed consent’ procedures. 
In the absence of definitive efficacy and effectiveness 
data to inform prescribing practices, clinicians are guided 
by clinical teaching and experience and extrapolation of 
efficacy and safety data from adults. This has encouraged 
the routine ‘off-label’ application of antianxiety drugs 
with US Food and Drug Administration (FDA) indications in 
adults, to disorders in children and adolescents 
(Labellarte et al., 1998). Currently, three selective 
serotonin reuptake inhibitor antidepressants (fluoxetine, 
sertraline, and fluvoxamine) have FDA approval for the 
treatment of another childhood anxiety disorder, obsessive-
compulsive disorder. Fluvoxamine and fluoxetine have also 
demonstrated efficacy for generalised anxiety disorder, 
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separation anxiety disorder, and social phobia in youth but 
do not have FDA indications for these disorders in this age 
group (RUPP, 2001; Birmaher et al., 2003). 
 
Treatment approaches for childhood posttraumatic stress 
disorder (PTSD) are diverse with little consensus on the 
effectiveness of many of the modalities in use. In a 
published survey of current practices of psychiatrists and 
non-medical therapists in the treatment of traumatised 
children and adolescents with PTSD; cognitive-behavior 
therapy (CBT) was endorsed as the most preferred first-line 
treatment among non-medical therapists and the second most 
preferred among psychiatrists for childhood PTSD (Cohen et 
al., 2001). Although only 17% of psychiatrists said they 
preferred psychotropic medications, the majority (95%) 
prescribed medications for the disorder. Both groups rated 
SSRIs as the most effective medications for treating 
overall PTSD symptoms. 
 
Many of the symptoms of PTSD can be traced to core symptoms 
of physiological hyperarousal (viz., sleep difficulties, 
nightmares, night terrors, generalised anxiety symptoms) 
which, in turn, can trigger a cascade of interrelated 
problems, such as difficulties maintaining adult and peer 
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relationships, difficulties with intimacy, poor school 
performance, and poor self-esteem. Perry and Azad (1999) 
have suggested that successful treatment may require 
‘modifying’ or ‘containing’ this physiological 
dysregulation, through the use of medication and/or 
psychotherapeutic treatment (to address mastery of specific 
fears and issues related to self-esteem, competence, and 
social skills). 
 
While it is arguable that the treatment of anxiety 
disorders in youth needs to be multifaceted, 
pharmacotherapy may be an appropriate first-choice when 
dealing with (i) serious and disabling anxiety symptoms and 
(ii) older children and adolescents (Bernstein et al., 
1996). Effective pharmacological agents for children and 
adolescents are ideally those which: a) will target 
disabling symptoms, b) improve the quality of life of the 
child/adolescent allowing for normal growth and development 
in the long-term, and c) facilitate the process of 
psychotherapy by allowing traumatised children to deal with 
emotionally distressing material and work through their 
distress (Donnelly and Amaya-Jackson, 2002). Pharmacologic 
agents that have been assessed in open trials have included 
clonidine (Harmon and Riggs, 1996), guanfacine (Horrigan, 
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1996), propranolol (Famularo et al., 1988), carbamazepine 
(Looff et al., 1995) and tricyclic antidepressants, and 
these are discussed here. To date, there are no published 
placebo-controlled trials of pharmacologic agents in 
children with PTSD.  
 
1.3.1 Adrenergic agents 
The finding that stress produces marked increases in brain 
noradrenergic function and that fear conditioning is 
related to alterations in noradrenergic activity may be 
important in understanding the pathophysiology of PTSD 
(Charney et al., 1993). Many of the symptoms experienced in 
PTSD (such as panic attacks, insomnia, exaggerated startle, 
and autonomic hyperarousal) are characteristic of increased 
noradrenergic function. Drugs like opiates and 
benzodiazepines either attenuate or decrease the stress-
induced increases in norepinephrine release (Charney et 
al., 1993). Adrenergic agents (e.g. the α2-adrenoreceptor 
antagonists clonidine and guanfacine, and the β-
adrenoreceptor antagonist, propranolol) which reduce 
sympathetic arousal have been shown to be effective in 
treating the hyperarousal, re-experiencing, and impulsivity 
seen in PTSD. In two open-label trials, oral clonidine 
(0.05 to 0.1 mg/day) (Perry, 1994) and clonidine 
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transdermal patches (0.1 to 0.2 mg/day) (Harmon and Riggs, 
1996) were effective in reducing PTSD symptoms in children, 
particularly anxiety, arousal, insomnia, impaired 
concentration, and impulsive and aggressive behaviour. 
Guanfacine was reported to be effective in reducing 
nightmares in a single case study (Horrigan, 1996), while 
propranolol significantly reduced intrusion and arousal 
symptoms over 5 weeks in 8 of 11 abused children with PTSD 
(Famularo et al., 1988). 
 
1.3.2 Serotonergic agents 
Animal models of PTSD suggest that serotonergic pathways 
may mediate certain avoidance behaviors, while clinical 
studies of paroxetine platelet binding and mCPP challenge 
tests further suggest a role for serotonin in PTSD 
(Southwick et al., 1997; Arora et al., 1993). For example, 
mCPP (a serotonin agonist) has been shown to induce panic 
attacks, flashbacks, and dissociative episodes in a 
significant number of adult combat veterans compared with a 
control group (Southwick et al.1997). In addition, veterans 
in the sample who had panic attacks induced by mCPP 
differed from patients who had panic attacks induced by 
yohimbine. Thus, it may be hypothesised that there are two 
distinct subgroups of PTSD: a group of patients with a 
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sensitised serotonergic system and another with a 
sensitised noradrenergic system. This finding, although not 
yet empirically tested in adults or children, may have 
implications for treatment in the clinical setting insofar 
as trying to match PTSD subtypes with appropriate 
pharmacological interventions.          
 
Selective serotonin reuptake inhibitors (SSRIs) are widely 
used to treat adult PTSD. Two SSRIs, sertraline and 
paroxetine, are currently the only two FDA-approved 
pharmacological agents indicated for adult PTSD. In adults, 
several randomized, controlled acute treatment trials of 
sertraline, paroxetine, and fluoxetine have been conducted, 
as well as open trials of fluvoxamine and citalopram (Asnis 
et al., 2004). Studies in adult PTSD have predominantly 
included women with chronic PTSD (mean duration > 10 years) 
secondary to rape or physical assault. Fluoxetine was the 
first SSRI to be investigated in the treatment of PTSD. In 
contrast to several controlled studies that did not show a 
significant benefit for either fluoxetine or sertraline in 
male combat veterans, published studies in predominantly 
female, non-combat subjects have been positive. These 
studies have demonstrated that SSRIs are effective in the 
short-term (6-12 weeks) and that continuation and 
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maintenance treatment for 6-12 months decreases relapse 
rates (Asnis et al., 2004). Furthermore, meta-analyses of 
efficacy studies in adult PTSD suggest that the effect size 
of the SSRIs are moderate to strong compared with placebo 
(Penava et al., 1997; Stein et al., 2000).  
 
The safety profile of the SSRIs, are also superior to those 
of the tricyclic antidepressants, they do not require the 
therapeutic drug monitoring required of the TCAs and are 
relatively safe in overdose. This factor is particularly 
important in children who are more susceptible to the toxic 
effects of TCAs, resulting from the increased production of 
cardiotoxic metabolites of these drugs, than adults 
(Leonard et al., 1997). Despite the lack of controlled 
trials of the SSRIs in childhood PTSD, they are currently 
recommended as a first-choice pharmacologic treatment in 
children and adolescents (AACAP, 1998; Donnelly and Amaya-
Jackson, 2002). Serotonergic agents, other than SSRIs, such 
as nefazodone and cyproheptadine have been used in this age 
group but controlled data are lacking (Domon and Andersen, 
2000; Gupta et al., 1998). Domon and Andersen (2000) found 
the serotonin-2 antagonist, nefazodone, to be effective in 
an open-label trial of adolescents with PTSD, particularly 
for symptoms of anger, aggression, insomnia, hyperarousal, 
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and concentration difficulties. Mirtazapine, a novel drug 
with both serotonergic and noradrenergic properties was 
used as augmentation in an 8-year old with PTSD and 
comorbid anxiety disorder not otherwise specified (Good and 
Petersen, 2001). The addition of mirtazapine (7.5 mg/day) 
to an SSRI resulted in improvement in PTSD symptoms. In 
adults with PTSD, a placebo-controlled, double-blind trial 
of mirtazapine demonstrated effects significantly in favor 
of mirtazapine and the drug was found to be well tolerated 
(Davidson et al., 2003). 
 
1.3.3 Other agents   
Randomised clinical trials have demonstrated efficacy of 
tricyclic antidepressants and monoamine oxidase inhibitors 
in adult PTSD, however no controlled studies have been 
reported in childhood PTSD. To date there has been one 
double-blind randomised study on the use of a low dose 
tricyclic antidepressant in the context of acute stress 
disorder in children with burn injuries. Imipramine was 
compared to chloral hydrate over a 7-day period in 25 
children with ASD (Robert et al., 1999) and was found to be 
superior in treating ASD symptoms. In a more naturalistic 
study, Saxe et al. (2001) investigated the use of an opiate 
medication (morphine) as a possible preventive agent in 
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children with burns-related PTSD. The dose of morphine 
administered to children during hospitalisation for burn 
injuries was associated with a significant reduction in 
PTSD symptoms over a 6-month period.   
  
Anticonvulsants have also been investigated in child and 
adult PTSD, their potential utility based on the premise 
that trauma exposure may induce sensitisation or kindling 
phenomena in limbic areas in the central nervous system. 
Looff et al. (1995) reported on the use of carbamazepine 
(300mg to 1200 mg/day) in 28 children and adolescents with 
sexual abuse histories. Twenty-two of these patients were 
asymptomatic at the end of treatment with regard to PTSD 
symptoms, while 6 continued to experience abuse-related 
nightmares. However, 50% of the sample had comorbid 
disorders (e.g., attention-deficit hyperactivity disorder, 
major depression, polysubstance abuse) and were being 
treated with concomitant medications (e.g., SSRIs, 
imipramine, methylphenidate, clonidine).  
 
The utility of benzodiazepines for pediatric PTSD has not 
been established. In adults, alprazolam and clonazepam have 
been shown to reduce anxiety and insomnia but not to have 
significant effects on the PTSD symptom clusters (Braun et 
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al., 1990; Lowenstein et al., 1988). Controlled studies of 
benzodiazepines for childhood anxiety disorders other than 
PTSD (e.g., panic disorder, and school refusal) have shown 
superiority of these agents over placebo (Bernstein et al., 
1990; Kutcher et al., 1992). While benzodiazepines may be a 
useful adjunct to antidepressant treatments, their 
potential for dependence and other adverse effects makes 
them less than an ideal choice in this population. 
Additionally they may negatively impact on behavioral 
therapy in children and adolescents.  Antipsychotic agents, 
including the dopamine D2 receptor blocking agent 
risperidone (Horrigan, 1998) and the predominant D1 
receptor blocking agent clozapine (Kant et al., 2004) have 
also demonstrated promise in small open studies of 
adolescents with chronic PTSD.  
 
In summary, there is a growing database in children and 
adolescents that suggests that medication treatments for 
PTSD cannot be ignored. In particular, the SSRIs may be 
useful and research in the area is deserving of further  
attention. Furthermore, care needs to be taken in 
extrapolating data from adults to children, given that 
there is some preliminary evidence of developmental 
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alterations in the efficacy of these agents (Keller et al., 
2001).  
 
Finally, the absence of published open-label or controlled 
trials of SSRIs in childhood PTSD provided the impetus to 
conduct a preliminary open-label study of an SSRI in 
adolescent PTSD to evaluate its efficacy on PTSD symptom 
clusters. The study rationale, methods and results are 
described in chapter 4. 
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1.4  Questions for Further Study    
In view of the questions raised concerning risk factors 
(e.g., the role of gender), clinical subtypes (e.g., the 
distinction between full and partial PTSD syndromes), and 
appropriate pharmacotherapy for this age group, a series of 
studies was undertaken: - 
 
First, a community-based school survey was conducted to 
assess the: (i) type and extent of violent trauma exposure, 
(ii) prevalence and pattern of PTSD symptoms (including 
differentiation of full symptom & partial symptom PTSD), 
and (iii) interactional effects of gender with trauma and 
PTSD in two African cities (Cape Town and Nairobi). 
Approximately one thousand adolescents were selected from 
nine schools in each city using a stratified sampling, 
cross-sectional survey design. The key statistical 
variables of interest were type of trauma and socio-
demographic factors(in particular gender) as potential risk 
factors for PTSD in the context of setting (Cape Town 
versus Nairobi). Prior to the initiation of this study, a 
preliminary survey conducted at three secondary schools 
(n=307) in Cape Town (Seedat et al., 2000) found high rates 
of PTSD (12.1%), with girls reporting more trauma exposures 
and PTSD symptoms than boys.  Given these preliminary 
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findings and given the higher rates of current criminal 
violence in South Africa, it was hypothesised that higher 
rates of trauma exposure and posttraumatic stress disorder 
would be endorsed by South African adolescents; in 
addition, female adolescents in both South African and 
Kenyan samples would endorse considerably higher rates of 
PTSD than boys. The study is detailed in Chapter 2.  
 
Second, characteristics of trauma and PTSD were assessed in 
a treatment-seeking clinic sample of trauma-exposed 
adolescents (described in Chapter 3). The aims were to:  
(i) examine the frequency of traumatic events, full and 
partial PTSD symptoms, other psychopathology (e.g., 
depression and anxiety), and functional impairment, (ii) 
differentiate which types of exposure were most likely to 
be associated with symptom expression, for example, PTSD 
and depression, as these are frequently comorbid and may 
have implications for treatment, and (iii) describe the 
profile of PTSD symptom clusters in a clinic-based sample. 
With respect to the study detailed in chapter 2, the 
objectives were to: (i) compare demographic and 
phenomenological differences in clinic-based and community-
based adolescents presenting with violent trauma exposure, 
and (ii) clarify whether PTSD symptom cluster profiles in 
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trauma-exposed adolescent clinic attendees (i.e. a 
potentially ‘high-risk’ sample) were distinct from that in 
community-based trauma-exposed adolescents (i.e., a 
potentially ‘low risk’ sample).        
 
Third, although SSRIs are a first line pharmacotherapy in 
adults with PTSD, the question arises as to whether this is 
appropriate pharmacotherapy for adolescents with the 
disorder. Chapter 4 details an open-label trial of a 
selective serotonin reuptake inhibitor (SSRI) in a sub-
sample of treatment-seeking children and adolescents 
derived from the sample described in Chapter 3. Adolescents 
with moderate to severe PTSD were treated with the SSRI, 
citalopram, which has a high selectivity for serotonin 
reuptake inhibition and a low potential for drug 
interactions. Based on preliminary results of efficacy and 
safety emanating from this small sample study, a second 8-
week trial of citalopram was undertaken in a larger sample 
of adolescents and, in this second trial, between-group 
differences in response to citalopram between adolescents 
and adults was also compared. It was hypothesised that 
citalopram would demonstrate efficacy in adolescents, as 
demonstrated by a significant reduction in all three PTSD 
symptom cluster scores (intrusive, avoidance, 
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hyperarousal). In a comparison with adults who would be 
treated with the same agent, it was hypothesized that both 
the magnitude of symptom reduction and the time to 
improvement would be in line with adult findings. A 
comparison of the two groups with respect to demographic 
features, index trauma type, multiplicity of exposure, and 
onset/duration of PTSD symptoms was also conducted and 
these findings are presented in Chapter 5. 
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2.  EPIDEMIOLOGY AND PHENOMENOLOGY OF POSTTRAUMATIC    
    STRESS DISORDER IN A COMMUNITY SAMPLE 
 
Trauma Exposure and Posttraumatic Stress Symptoms in 
Adolescents: A Schools’ Survey in Cape Town (South Africa) 
and Nairobi (Kenya) 
 
2.1 Study Summary 
There is a lack of comparative data on the prevalence and 
effects of violence exposure in African youth. This study 
assessed trauma exposure, posttraumatic stress symptoms, 
and gender differences in adolescents from two African 
countries. Two thousand and forty one boys and girls from 
18 schools in Cape Town and Nairobi completed anonymous 
self-report questionnaires.  
 
More than 80% reported exposure to severe trauma, either as 
victims or witnesses. Kenyan adolescents, compared with 
South African adolescents, had significantly higher rates 
of exposure to witnessing violence (69% vs. 58%), serious 
accidents (33% vs. 26%), physical assault by a family 
member (27% vs. 14%) and sexual assault (18% vs. 14%).  
However, rates of current full symptom PTSD (22.2% vs.4.7%) 
and current partial symptom PTSD (11.9% vs. 8.2%) were 
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significantly higher in the S.A. sample. Boys were as 
likely as girls to meet PTSD symptom criteria.  
 
While lifetime exposure to trauma was comparable across 
both settings, Kenyan adolescents had much lower rates of 
PTSD. This difference may be attributable to cultural and 
other trauma-related variables. High rates of sexual 
assault and PTSD, traditionally documented in girls, may 
also occur in boys and warrants further study. 
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2.2 Background 
Globally great variability exists in the estimates of 
violence exposure in community samples of adolescents. 
Surveys in the United States have consistently observed 
high rates of violence and victimisation among urban 
adolescents, with some studies reporting rates ranging from 
9% to 42% for experiencing and witnessing serious violence 
(American School Health Association, 1989; Center for 
Disease Control and Prevention, 1992; Schubiner et al., 
1993). In a national telephone sample of youth aged 10 to 
17 years in the United States, over one third reported 
being victims of assault and victimised adolescents 
displayed significantly more psychological and behavioural 
symptomatology than nonvictimised respondents (Boney-McCoy 
and Finkelhor, 1995).  
 
The phenomenon of community violence exposure is 
conceptually complex as it applies not only to direct 
personal exposure, but also exposure through witnessing and 
vicarious means (Foy and Goguen, 1998). Community violence 
exposure has been reliably linked with diverse mental 
health and behavioural sequelae including depression, 
anxiety, posttraumatic stress, low self-esteem, self-
destructive behaviour and aggression (Richters & Martinez, 
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1993; Fitzpatrick & Boldizar, 1993; Giaconia et al., 1995). 
The constructs of community violence exposure and 
psychological sequelae appear to be directly related, with 
exposure to violence positively and linearly related to 
psychological distress, and more exposure to violence 
associated with more self-reported posttraumatic stress 
disorder (PTSD) and depressive symptomatology (Rosenthal 
and Wilson, 2001; Ozer and Weinstein, 2004).  Indeed, both 
direct (e.g. being victimised) and indirect (e.g., 
witnessing violence) violence exposure have demonstrated 
independent (as well as overlapping) relationships with 
traumatic symptoms (Rosenthal, 2000), and it has been 
suggested that not only are PTSD symptoms significantly 
associated with exposure to violence, but that PTSD 
symptoms may in fact mediate the relationship between 
exposure to violence and other forms of psychological 
distress, such as depression and suicidal ideation (Mazza 
and Reynolds, 1999).  
 
While many adolescents have to contend with chronic and 
high levels of violence exposure, specific factors relating 
to risk and resilience in adolescents remain unclear. Risk 
for community violence exposure is higher among the poor, 
non-white, and those who live in densely populated urban 
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areas (Fitzpatrick and Boldizar, 1993). Studies have also 
found that late adolescence (ages 15-19) represents the 
period of highest risk for community violence exposure (Foy 
and Goguen, 1998). With respect to the risk for PTSD, a 
review of 55 studies on youth found that 85% of studies 
that examined linkages between trauma exposure severity and 
PTSD symptomatology demonstrated significant relationships 
(McLain et al., 1998). Prior trauma exposure was also 
consistently associated with increased PTSD symptomatology. 
Age, gender, and ethnicity were significantly related to 
PTSD in some studies but the authors suggested that more 
studies are needed before definitive patterns can be 
discerned. More recent work suggests that social support 
alone may not be sufficient to “buffer’ the effect between 
exposure to community violence and psychological distress 
(Paxton et al., 2004). Furthermore, gender may be an 
important determinant of later trauma-related distress in 
adolescents. Studies have demonstrated higher rates of mood 
and anxiety symptoms in girls than boys (Pynoos et al., 
1993; Green et al., 1994). For example, in a study of 
African-Americans aged between 7 and 18 years (Fitzpatrick 
and Boldizar, 1993), boys were more likely than girls to be 
victims of, and witnesses to, violent acts, but PTSD 
symptoms were more severe in victimized girls.   
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As yet, there are no national large-scale epidemiological 
surveys of the prevalence of PTSD among children and 
adolescents in the general population; however, community 
studies in the United States have consistently indicated 
that approximately 40% of high school students have 
experienced some form of domestic or community violence and 
3% to 6% have PTSD (Giaconia et al., 1995; Cuffe et al., 
1998). Furthermore, few surveys have described the extent 
of violence exposure and its associated psychological 
outcomes in African youth. One recent survey (Ward et al., 
2001) involving four secondary schools (n=104) in Cape Town 
(South Africa) found that the majority of adolescents (more 
than 70%) were exposed to at least one type of violent 
event either as victims or witnesses, with 5.8% likely to 
meet criteria for post-traumatic stress disorder (PTSD). 
PTSD symptoms and depression were related to most types of 
violence exposure. In other cross-sectional studies of 
youth in rural and urban settings in South Africa (S.A.), 
high rates of violence exposure ranging from 67% to 95% 
have been documented, with 8.4% to 40% of children less 
than seventeen years of age fulfilling PTSD diagnostic 
criteria (Peltzer, 1999; Ensink et al., 1997). A 
significant positive relationship has also been identified 
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between the extent of exposure and the development of PTSD 
(Peltzer, 1998).  
 
To date, there has been only one randomised controlled 
school-based study on the effectiveness of psychological 
interventions for children with symptoms of PTSD resulting 
from, personal experience of, or exposure to, violence 
(Stein et al., 2003). Students at 2 large middle schools in 
Los Angeles (USA), who had reported exposure to violence 
and had clinical symptoms of PTSD, were randomly assigned 
to a 10-session school-based standardised cognitive-
behavioural therapy (CBT) early intervention or to a wait-
list delayed intervention comparison. The group who 
received the brief CBT intervention, delivered by school 
mental health clinicians on school premises, had 
significantly fewer reported symptoms of PTSD and 
depression than the wait-listed delayed intervention group. 
Notably, the magnitude of effect on child- and parent- 
reported outcomes was comparable to that of other child 
psychotherapy intervention trials for disorders other than 
PTSD, suggesting that such an intervention, incorporated 
into existing community-based programs and delivered by 
school-based psychologists, could be useful in settings 
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where accessibility to mental health services might be 
limited. 
 
With these data underscoring the high risk that adolescents 
are at for being victims of violent crime and with the 
apparent need for a better understanding of how specific 
violent experiences may or may not lead to adverse 
psychological experiences such as PTSD and depression 
within particular populations of youth, the aim of this 
survey was to compare trauma exposure and its sequelae, in 
particular rates of full and partial current PTSD symptoms, 
in grade 10 adolescents in public and private schools from 
two African cities. The key statistical differences of 
interest were type of trauma, gender, and risk for PTSD in 
the context of setting.  In a preliminary survey conducted 
at three secondary schools (n=307) in Cape Town (Seedat et 
al., 2000), we noted high rates of PTSD (12.1%), with girls 
reporting more trauma exposures and PTSD symptoms than 
boys.  Given these preliminary findings and given the high 
rates of current criminal violence in the country (Victims 
of Crime Survey, 1998), it was hypothesised that South 
African respondents, especially females, would endorse 
considerably higher rates of trauma and PTSD compared with 
Kenyan respondents.  It was also hypothesised that in the 
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sample as a whole (i) exposure to violence in adolescents 
would have a positive and significant association with 
posttraumatic stress disorder symptoms; (ii) exposure to 
multiple traumas would have a stronger association with 
PTSD symptoms, and (iii) gender effects in response to 
violent crime would be evident, with girls responding to 
violence with more PTSD symptoms than boys.  
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2.3 Methods 
2.3.1 Subjects 
The sampling pool comprised grade 10 students from 18 
schools in Cape Town (South Africa) and Nairobi (Kenya) who 
were surveyed during the 2000 school year. Seven public 
schools and two private urban schools were selected in each 
city to be representative of the ethnic and socio-economic 
make-up of the population. A stratified sampling procedure 
was used to select students in grade 10 at public and 
private high schools in Cape Town and Nairobi. Schools were 
stratified according to geographic area. One thousand one 
hundred and forty South African students and 901 Kenyan 
students participated. Their mean age was 15.8 years  
(SD = 0.98 years, range 10.5 to 22 years).  
 
2.3.2 Procedures 
The protocol was approved by the institutional review board 
(University of Stellenbosch) and the Departments of 
Education in Cape Town and Nairobi. Students and parents 
were notified in advance of the study. Participation was 
entirely voluntary and no student or parent opposed 
participation. All grade 10 students present on the day of 
the survey completed anonymous self-report questionnaires 
in English under the supervision of classroom teachers and 
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research assistants (master’s level) during a 45-60 minute 
classroom period at their schools. Within each school, all 
grade 10 adolescents who were present on the day of the 
survey participated. No attempt was made to substitute 
students if a class had absentees.  
 
2.3.3  Instruments 
(i) Demographics Questionnaire 
A demographics questionnaire was devised by the authors and 
included demographic information on age, gender, ethnicity, 
composition of the home, parental marital status, parental 
occupation, family income and substance use (cigarette 
smoking, alcohol, and other drug use). 
(ii) Trauma Checklist 
The Trauma Checklist, a list of DSM-IV qualifying traumas 
(e.g. being robbed or mugged, being physically hurt or 
attacked, being raped) was adapted from the Schedule for 
Affective Disorders and Schizophrenia for School-Age 
Children-Present and Lifetime version (K-SADS-PL) (Kaufman 
et al., 1997). Respondents were also required to circle the 
most frightening or upsetting event that ever happened to 
them. 
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(iii) Child PTSD Checklist 
After ascertaining the event that was the most frightening 
or upsetting, the Child PTSD Checklist (Newman and Amaya-
Jackson, 1996), a 28-item child-adolescent PTSD structured 
interview, was administered. The Child PTSD Checklist was 
developed to diagnose child-adolescent PTSD, however 
information about its psychometric properties have not been 
reported in the literature. For this survey, the scale was 
administered as a self-rated measure. The Child PTSD 
Checklist which rates the presence of each of the 17 PTSD 
symptoms (American Psychiatric Association, 2000) in the 
past month, was used to assess for current PTSD. The PTSD 
checklist yields 3 composite scores (for the 3 PTSD symptom 
clusters) and an overall score. The scale uses a 4-point 
Likert format with ‘0’ corresponding to “not at all” and 
‘3’ to “all of the time”. For the purpose of the study, 
respondents were asked to rate PTSD symptoms according to 
the most upsetting event endorsed on the Trauma Checklist. 
A conservative threshold of ‘2’ (i.e.  “most of the time”) 
was used to endorse the presence of a symptom. Partial 
symptom PTSD was defined as having at least one symptom in 
each DSM-IV symptom criterion category (Stein et al., 1997; 
Marshall et al., 2001). 
 
  
64
(iv) Life Events Questionnaire-Adolescent version (LEQ-A) 
The LEQ-A (Masten et al., 1994), a 45-item measure of 
negative and positive life events, was used to measure non-
PTSD events that can happen in the life of any adolescent 
or in any family. Respondents were required to indicate 
(‘yes’ or ‘no’) if an event had happened to them or their 
families in the past year. Discrete, negative life events 
included school failure and suspension, pregnancy, legal 
difficulties, and trouble with drugs and alcohol. 
(v) Beck Depression Inventory (BDI) 
The BDI is a widely used 21-item self-report measure of 
cognitive, affective, somatic and behavioural symptoms of 
depression with excellent psychometric properties (Beck & 
Steer, 1987). Internal consistency of the BDI has been 
reported to range from .73 to .92 with a mean of .86 (Beck 
et al., 1988). Meta-analysis of the scale’s psychometric 
properties suggest high content validity, and validity in 
differentiating between depressed and non-depressed 
individuals (Richter et al., 1998). Each item comprises 
four statements rated from 0 to 3. A total score for the 21 
items is obtained, with the lowest possible score being 0 
and the highest possible total being 63. High scores 
indicate more severe depression. In a school sample of 
adolescents who were screened with the BDI, a screening 
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score of 16 produced 100% sensitivity and 93% specificity 
(Barrera & Garrison-Jones, 1988).  
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2.4 Statistical Analyses 
All data was analysed using SPSS (version 10.0) for 
Windows. Demographic characteristics, exposure by trauma 
type, posttraumatic stress and depressive symptoms were 
assessed using frequency and descriptive statistics. Chi-
squared tests (and odds ratios) for categorical variables 
and student t-tests for numeric variables were used to 
explore the relationship between country, gender, trauma 
exposure, PTSD and depression. Pearson’s correlation 
statistics were used to correlate PTSD symptoms with BDI 
total scores. Fisher’s exact tests were done in place of 
chi-squared tests for independence when one or more cells 
in a 2 X 2 table had an expected count of less than 5. All 
tests were two-tailed and significance was set at p <.05. 
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2.5 Results 
2.5.1 Demographic characteristics 
Table 1 compares the demographic characteristics of S.A. 
and Kenyan respondents. There was a preponderance of girls 
in both groups. The majority of Kenyan respondents were 
Black while the majority of S.A. students were of mixed 
descent, representing the majority ethnic groups in these 
two cities (Nairobi & Cape Town). 38% of S.A. students were 
from homes characterized by single, divorced or widowed 
parents compared with 19% of Kenyan students.  
 
2.5.2 Pattern of trauma exposure 
More than 80% of all respondents (n=2041) reported lifetime 
exposure to at least one DSM-IV trauma (APA, 2000). The 
mean number of trauma exposures was 2.49 (SD=1.99, range= 0 
to 11). Results of comparisons by country were not 
statistically significant. For both S.A. and Kenyan 
respondents, the commonest traumas were witnessing 
community violence (63%), being robbed or mugged (35%) and 
witnessing a family member being hurt or killed (33%). 
However, significantly more Kenyan than S.A. respondents 
had witnessed violence, been in a bad accident, been 
physically hurt/ beaten by a family member or been sexually 
assaulted (Table 2).  
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2.5.3 PTSD symptoms 
The most common PTSD symptoms in descending order were: (i) 
avoidance of activities, places or people that aroused 
recollections of the trauma [S.A.: 33.3%, Kenya: 53.2%], 
(ii) avoidance of thoughts, feelings, or conversations 
associated with the trauma [S.A.: 32.4%, Kenya: 50.5%], 
(iii) irritability or outbursts of anger [S.A.: 31.1%, 
Kenya: 23.1%] and  (iv) intense psychological distress at 
exposure to traumatic reminders [S.A.: 21.3%, Kenya: 
28.0%].  
 
S.A respondents had higher scores across all the 3 symptom 
clusters (re-experiencing, avoidance, hyperarousal) and 
more PTSD symptoms than Kenyan respondents [S.A.: 4.9 
(±5.5); Kenya: 2.3 (±2.9), t=13.2, p <.001).  
 
14.5% [n=295] of adolescents met symptom criteria for full 
PTSD while an additional 10.3% [n=210] met symptom criteria 
for partial PTSD. Notably, 22.2% of S.A. adolescents had a 
full PTSD symptom diagnosis compared with only 4.7% of 
Kenyan adolescents (p <. 001) and 11.9% met symptom 
criteria for partial PTSD compared with 8.2% in the Kenyan 
group (p <.01).  
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2.5.4 Relationship between trauma exposure & PTSD symptoms 
Adolescents meeting symptom criteria for full PTSD (n=295) 
endorsed more traumas on the Trauma Checklist than 
adolescents without PTSD [3.5 (± 2.6) vs. 2.3 (± 1.8), t=-
9.7, p <.001). These differences remained significant in 
the analysis by country [PTSD+ vs. PTSD-: Kenya: 2.9 (±2.1) 
vs. 2.4 (±1.7) mean exposures, t=-2.1, p <. 05; S.A.: 3.6 (± 
2.7) vs. 2.2 (± 1.9) mean exposures, t=-9.1, p <. 001] and 
by gender [PTSD+ vs. PTSD-: Males: 3.7 (± 2.6) vs. 2.5 (± 
1.9) mean exposures, t=-6.3, p <. 001; Females: 3.2 (±2.5) 
vs. 2.2 (±1.8) mean exposures]. Respondents with full 
symptom PTSD were more likely to endorse a higher number of 
traumas (mean ± SD =3.7 ± 2.5) than those with partial 
symptom PTSD (mean ± SD = 2.9 ± 1.9) or no PTSD (mean ± SD = 
2.3 ± 1.8) (F = 58.9, p <. 001).  
 
2.5.5 Gender & trauma exposure  
Boys had a higher mean number of trauma exposures than 
girls (2.7 ± 2.0 vs. 2.3 ± 1.9, t=3.7, p <. 002). Boys were 
also significantly more likely than girls to have witnessed 
community violence (67% vs. 60%, Fisher’s exact test, p <. 
001), to have been robbed or mugged (39% vs. 33%, Fisher’s 
exact test, p <0.03), to have been beaten by a non-family 
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member (26% vs. 15%, Fisher’s exact test, p <. 001), and to 
have been victims of sexual assault (19% vs.13%, Fisher’s 
exact test, p <. 002) (Table 3). “Sexual assault’ was 
operationalised in the survey as ‘any unwanted and forceful 
sexual experience that made you feel uncomfortable’. When 
boys and girls were analysed by country, these differences 
remained significant in the Kenyan sample but not in the 
S.A. sample.  
   
2.5.6 Gender & PTSD Symptoms 
Boys and girls were equally likely to meet symptom criteria 
for full PTSD (χ2 = .96, p< .18, ns [not significant]) and 
partial PTSD (Fisher’s exact test, p < .07, ns). In the 
sample as whole, PTSD symptom clusters (re-experiencing, 
avoidance and hyperarousal symptoms) also did not differ 
significantly by gender. However, in the S.A. sample girls 
reported more re-experiencing and avoidance symptoms than 
boys (Table 4).  S.A. girls also had higher mean scores on 
the Child PTSD Checklist (indicative of greater symptom 
severity) (Females: 20.5 (± 15.6) vs. Males: 17.2 (± 14.4), 
t= -3.2, p < 0.001). 
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2.5.7 Lifetime trauma exposure, PTSD & ethnicity  
Table 5 shows lifetime trauma exposure rates and rates of 
PTSD across the major ethnic groups in the sample.  Among 
the majority ethnic grouping in the sample (mixed descent), 
85% reported exposure to trauma with 25% of those exposed 
meeting criteria for a PTSD symptom diagnosis. In the 
Kenyan sample, 75% of the majority ethnic grouping (Black) 
endorsed trauma exposure. However, only 5% met PTSD symptom 
criteria.  
 
2.5.8 Trauma type & PTSD risk 
Based on respondents’ selection of the most frightening or 
upsetting event, the 3 traumas most likely to be associated 
with a PTSD symptom diagnosis were: sexual assault (χ2 = 
38.9, p <. 001, odds ratio [OR] = 2.5, 95% CI [1.8-3.3]), 
physical assault by a family member (χ2 = 43.3, p <. 001, 
OR=2.3, 95% CI [1.8-2.9]), and serious accidents (χ2 = 33.5, 
p <. 001, OR=2.2, 95% CI [1.7-2.9]). The risk of PTSD 
following sexual assault was the same for girls (24% of 
sexually assaulted girls, Fisher’s exact test, p <. 001, 
OR=2.3) as it was for boys (25% of sexually assaulted boys, 
Fisher’s exact test, p <. 001, OR=2.3). 
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2.5.9 Regression analysis 
All trauma exposures were then entered as independent 
variables into a stepwise regression equation to examine 
the relationship between type of trauma exposure and the 
risk for PTSD. The dependent variable was a PTSD (full) 
symptom diagnosis. Traumas that constituted independent 
predictors for PTSD were: (i) sexual assault (p < .001, exp 
(B) =. 53, 95% CI [0 .39 -.72]), (ii) witnessing family 
members injured, beaten, hurt or killed (p<. 001, exp (B) 
=. 55, 95% CI [0.42 - 0.72]), (iii) being in a bad accident  
(p <. 001, exp (B) = .56, 95% CI [0.41 - 0.75]),  (iv) 
being robbed or mugged (p <. 04, exp (B) = .74, 95% CI 
[0.56 - 0.98]),  (v) being beaten or physically hurt by a 
family member (p <. 03, exp (B) = .69, 95% CI [0.63 – 
1.22]) and, (vi) witnessing violence in the street, 
neighbourhood or school (p < .02, exp (B) = 1.47, 95% CI 
[1.09-1.97]). Physical attack by a non-family member (p < 
.432) and natural disasters (p < .096) were not 
independently predictive of a PTSD symptom diagnosis.  
 
2.5.10 Depression 
For the sample as a whole, mean BDI scores were in the 
‘mild’ range for depression (11.5 ± 16.7). No significant 
country [Kenya:  12.2  (± 23.2); S.A.: 11.1 (± 10.5)] or 
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gender [Males: 10.8 (± 9.7) vs. Females: 11.4 (± 10.0)] 
differences were observed. In the Kenyan group, but not in 
the S.A. group, girls reported more depressive symptoms and 
had significantly higher scores on the BDI than boys 
[Females:  12.4 (± 9.3) vs. Males: 9.5 (± 7.9), t = -3.6, p 
<. 001] (Table 4). 
 
2.5.11 Correlation between PTSD & depression  
Number of PTSD symptoms endorsed on the PTSD Checklist 
(Newman and Amaya-Jackson, 1996) correlated significantly 
with total BDI scores (r = .29, p <. 001). Statistical 
significance was retained in the analyses by country 
[Kenya: r = .20, p <. 001; S.A.: r= .52, p <. 001] and 
gender [Males: r = .48, p <. 001; Females: r =. 51, p <. 
001].  Respondents with full symptom PTSD also had higher 
mean BDI scores (mean ± SD = 20.0 ±11.4) than those with 
partial symptom PTSD (mean ± SD=13.6 ± 9.6) and those with 
no PTSD (mean ± SD = 9.4 ± 17.8) (F=37.5, p <. 001).  
 
2.5.12 Substance use 
More S.A. adolescents than Kenyan adolescents reported 
smoking cigarettes (≥ 10 cigarettes per day) (5.3% vs. 0.4%, 
p <. 001) and cannabis (10.6 % vs. 1.7%, p < .001). In the 
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sample as a whole, more boys than girls reported cannabis 
use (8.7% vs. 4.6%, p < .001). However, no significant 
gender differences were noted for cigarette and alcohol 
use. Use of these substances did not correlate 
significantly with PTSD symptoms.   
 
2.5.13 Negative life events 
S.A. respondents reported a higher number of past year 
exposures to negative life events on the Life Events 
Questionnaire (S.A.: mean=9.2 ± 5.2, Kenya: mean=8.3 ± 4.7, 
t=4.2, p <. 001), that included doing much worse than 
expected in a test/ examination and breaking up with a 
boyfriend/girlfriend. Negative life event exposure was not 
significantly associated with PTSD symptoms (total sample:  
p =. 170; S.A.: p =. 372; Kenya = p =. 562). Further, 
adolescents who endorsed 1 or more traumas plus 1 or more 
negative life events were not more likely to meet PTSD 
symptom criteria (χ2 = .66, p = .363).   
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2.6 Discussion 
2.6.1 PTSD & trauma 
14.5% of adolescents (i.e. 14.8% of those traumatized) 
fulfilled criteria for a full symptom diagnosis of PTSD 
while an additional 10.3% (i.e. 11.4% of those traumatized) 
fulfilled partial PTSD criteria. These rates are strikingly 
similar to rates previously documented in trauma samples. 
In study by Giaconia et al. (1995), 14.5 % of affected 
youth (6.3% of the total sample) met DSM-III-R criteria for 
PTSD, while Lipschitz et al., 2000) found that 14.4% and 
11.6% of traumatized girls met DSM-IV symptom criteria for 
full and partial PTSD, respectively. It is noteworthy that 
recent findings support the hypothesis that children with 
partial/ subthreshold criteria may not differ significantly 
from children meeting all three cluster criteria (re-
experiencing, avoidance, hyperarousal) with regards to 
functional impairment and distress. For example, in a study 
by Carrion and colleagues (2002), children with 
subthreshold PTSD had functional impairment that was 
specific to PTSD symptoms and was not due to comorbidity. 
This suggests, therefore, that it might be more precise to 
make a diagnosis of PTSD in children and adolescents based 
on the intensity of symptoms and their relationship to 
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functional impairment than on the threshold number of 
symptoms.  
 
Both countries had high rates of trauma exposure with 83 % 
of S.A adolescents and 85% of Kenyan adolescents reporting 
at least one DSM-IV trauma in their lifetime, echoing the 
findings of other local (South African) and international 
studies (Ensink et al., 1997; Peltzer, 1999 American School 
Health Association, 1989; Giaconia et al., 1995). A 
noteworthy finding was that both direct (i.e., direct 
victimisation) and indirect (e.g., witnessing violence) 
types of violence exposure were predictive of PTSD symptom 
status.  
 
2.6.2 Differences between S.A. & Kenyan respondents 
The most striking finding was the discrepancy in the rate 
of PTSD between S.A. and Kenyan adolescents in the context 
of equally high rates of trauma exposure (and even higher 
rates for specific types of trauma in the Kenyan sample). 
The lower rate of PTSD in Kenyan adolescents is difficult 
to explain. The assessments did not measure the severity or 
chronicity of trauma exposure or past PTSD, variables that 
may contribute to PTSD risk. For example, differences in 
toxicity of exposure between the samples (much higher 
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levels of exposure to violent crime in South African 
adolescents) may be operant here accounting to some extent 
for the difference in PTSD rates. 
  
Could cultural factors be responsible? Cultural differences 
are known to exist in the way that concepts of ‘trauma’, 
trauma exposure, and PTSD symptoms are operationalised and 
understood in different ethnic groups. Our survey 
questionnaires were not culturally validated in the various 
ethnic groups in which they were used and the likelihood of 
cultural response bias to questionnaire items cannot be 
excluded. Further, compared with the S.A. sample in which 
the cultural contexts of the different communities were 
diverse, the ethnic composition of the Kenyan sample was 
relatively homogenous. More than 97% of Kenyan students 
were Black compared with only a fifth of South African 
students.   
 
2.6.3 Gender  
In this study, boys had a higher mean number of trauma 
exposures and higher rates of exposure to certain types of 
assaultive violence (e.g. robbing or mugging, beating by a 
non-family member, sexual assault) compared with girls. Not 
all studies have noted gender differences in trauma 
  
78
exposure. Giaconia et al. (1995), in a community study of 
18 year-olds, found that overall rates of trauma were the 
same for both boys and girls. Other studies have reported a 
greater incidence of trauma exposure in boys (Breslau et 
al., 1991; Vrana and Lauterbach, 1994; Schwab-Stone et al., 
1999).  
 
A surprising finding was the absence of a gender difference 
in the overall rate of PTSD. Several studies have 
demonstrated a much greater risk for PTSD (up to 6-fold) in 
females (Breslau et al., 1991; Green et al., 1994; Giaconia 
et al., 1995; Berton and Stabb, 1996; Curle and Williams, 
1996; March et al., 1997; Jaycox et al., 2002). For 
example, Singer et al. (1995) surveyed a diverse sample of 
high-school students (n=3735) selected from large-city, 
small-city, and suburban schools, and reported that female 
gender was the strongest demographic predictor of trauma 
symptoms, including posttraumatic stress, depression, 
anxiety, anger, dissociation and total trauma symptoms. In 
another recent study of adolescents exposed to a disaster 
(fire), increases in self-reported anxiety, depression, 
aggression, and self-reported excessive use of alcohol were 
seen, with increases in all these effects larger in girls 
than boys (Reijneveld et al., 2003).  
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Similarly, in a national household probability sample of 
4,023 telephone-interviewed adolescents ages 12-17 in the 
USA, the 6-month prevalence of PTSD was 3.7% for boys and 
6.3% for girls (Kilpatrick et al., 2003).  
 
The findings reported here are consistent with those 
described by Silva et al. (2000) who, in a clinic sample of 
traumatized inner-city youth (n=59), found no significant 
differences in terms of the interaction of trauma 
(including sexual abuse) and gender, and no difference in 
the mean number of PTSD symptoms. 22% of 59 traumatised 
children met full criteria for PTSD, 32% had partial 
symptoms and 46% had no PTSD symptoms.  
 
Another unexpected finding was that while boys and girls 
were equally likely to have experienced at least one 
lifetime trauma, more boys than girls endorsed sexual 
trauma. While studies of young adolescent males in 
developing countries have shown that they are also not 
uncommonly subject to various forms of sexual assault (for 
example, a chart review study in the Cameroon of 5,082 
children presenting at a medical clinic found that boys 
comprised 4.8% of those abused) (Menick and Ngoh, 1998), 
most studies would suggest that girls are far more likely 
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than boys to be sexually assaulted (i.e., to be victims of 
completed or attempted rape) (Fehon et al., 2001; Fergusson 
et al., 2002; Walker et al., 2004). Indeed, this is 
consistent with the findings of a recent study in 
adolescent high school students in Cape Town, which found 
that girls are about four times more likely than boys to 
have been victims of sexual abuse (King et al., 2004).  
 
The risk of developing PTSD following sexual assault was 
the same for both sexes (OR= 2.3). Sexual assault, compared 
with all other traumas, was also associated with the 
highest risk of PTSD. This finding parallels that of other 
workers who have found a relatively higher risk for PTSD 
(up to 12-fold) following rape or sexual assault compared 
with other types of trauma (Breslau et al., 1991; Green et 
al., 1994; Giaconia et al., 1995).  
 
We found that depression, but not substance use, correlated 
with PTSD. Girls had higher depression scores than boys, 
consistent with previous work (Lewinsohn et al., 1993; 
Schraedley et al., 1999). Further, respondents with more 
PTSD symptoms (i.e. those with full PTSD) tended to have 
more depressive symptoms than those with partial symptoms 
or no PTSD. In contrast, the only published paediatric 
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study to compare the constructs of full and 
partial/subthreshold PTSD found no significant differences 
in comorbidity (e.g., major depressive disorder) or 
functional impairment between children (aged 7 to 14 years) 
with full or PTSD (Carrion et al., 2002).  
 
2.6.4 Clinical implication of findings 
 
 High rates of full symptom PTSD (14.5%) and partial 
symptom PTSD (10.3%) characterise African youth, 
mirroring findings in Western settings. 
 Discrepant rates of PTSD between Kenyan and S.A. 
adolescents in the presence of comparable rates of 
trauma exposure, suggest that other factors (e.g. 
differences in trauma toxicity, cultural variables) 
may be operant in contributing to risk.  
 Boys in the sample endorsed more sexual traumas than 
girls. Compared with all other traumas, sexual assault 
was associated with the highest risk for PTSD.   
 The above findings lend support to the growing 
literature on the positive relationship between 
exposure to violence and psychological distress and 
should be a consideration in designing school-based 
violence prevention programs in African community 
settings.  
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2.6.5 Limitations 
Several limitations are worth mentioning. First, while we 
used a relatively high symptom threshold of “most of the 
time’ to establish PTSD criteria, diagnoses of current PTSD 
(full and partial) were based solely on symptom status and 
not on functional impairment. For partial PTSD, the 
presence of at least 1 symptom from each symptom category 
(criteria sets B, C, and D) was employed (Stein et al., 
1997; Marshall et al., 2001). Second, as the age of onset 
and duration of PTSD were not documented, we were not able 
to establish symptom chronicity. Third, exposure to trauma 
was measured as a count of the type of trauma, rather than 
as the number of exposures or the severity of exposure to a 
particular trauma. This may have impacted, to some extent, 
on the failure to detect significant differences between 
the samples, particularly as cumulative and toxic trauma 
exposure is associated with a higher PTSD risk. It does 
not, however, account for higher rates of PTSD in S.A. 
youth, despite higher rates of exposure in Kenyan youth to 
both sexual assault and physical assault by a family member 
as these are traumas that, if present, are likely to be 
repeated. These traumas were also the ones most likely to 
be associated with a PTSD symptom diagnosis. This 
discrepancy is one for which we do not have an adequate 
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explanation. Finally, survey questionnaires were not 
culturally validated and all questionnaires were 
administered in English (i.e., to be eligible participants 
had to be able to read and write English at 10th grade 
level), although English was not the home language of the 
majority of respondents.  
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2.7 Conclusion 
 
In conclusion, replication across other ethnic and cultural 
settings in the African context is required to more clearly 
establish the nature and extent of trauma exposure and its 
psychological repercussions in African youth. Nevertheless, 
these findings share many similarities with studies 
undertaken in Western countries. They highlight the high 
rates of violence exposure and PTSD in both boys and girls 
and suggest a need for health care professionals to be more 
vigilant in screening for victimization and trauma-related 
distress. In view of a paucity of mental health 
interventions that can be effectively delivered within the 
constraints of community settings, these findings further 
highlight the need for such programs and the important role 
that could be played by school-based clinics in providing 
such services.  
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TABLE 1: Demographic Characteristics  
 
 
Demographic Variables 
 
S.A.  
(n=1140) 
 
KENYA 
(n=901) 
Age in years (SD) *  15.9 (1.1)   15.6 (0.8)
Gender             
     Male 
     Female 
 
  43.3 % 
  56.7 % 
   
   41.9 % 
   58.1 % 
Ethnicity*              
•White 
          •Mixed descent 
          •Black 
          •Asian 
          •Other 
  
  32.1 % 
  42.2 % 
  21.3 % 
   2.1 % 
   2.3 % 
   
    0.3 % 
   ---- 
   97.7 % 
    0.6 % 
    1.4 % 
Habits (current use)             
     Cigarettes: ≥ 10 per day* 
     Alcohol > 3 times per week 
     Cannabis*          
   
   5.3 % 
   1.2 % 
  10.6 % 
  
    0.4 % 
    1.1 % 
    1.7 % 
Parental Marital Status* 
      Married/living together 
     Single/divorced/widowed 
 
  62.0 % 
  38.0 %  
 
   81.0 % 
   19.0 % 
Parental Unemployment  
     Mother  
     Father 
 
  27.6 % 
  14.6 % 
 
   16.6 % 
    4.9 % 
 Total   (N)    1140     901 
* denotes significant differences (p < .001) between the 
countries 
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TABLE 2: Trauma Exposure Type and PTSD Symptom Diagnosis  
 
 
Common Trauma Types 
 
 
S.A.  
(n=1140) 
 % (count)  
 
KENYA 
(n=901) 
 % (count) 
 
   p 
Exposure to ≥ 1 trauma 
Exposure to ≥ 3 traumas 
83 % (943) 
44 % (499) 
85 % (764) 
45 % (406) 
 ns 
 ns 
Witnessing violence in the 
street, neighbourhood, or school  
 
58 % (660) 
 
69 % (619) 
 
<. 001 
Being robbed or mugged 34 % (386) 37 % (331)  ns 
Being in a bad accident  26 % (291) 16 % (140) <. 001 
Being in an earthquake, fire, 
flood, or other natural disasters 
 
16 % (184) 
 
16 % (139) 
 
  ns 
Seeing family members injured, 
beaten, hurt, or killed  
 
33 % (377) 
 
32 % (286) 
 
  ns 
Being beaten or physically hurt 
yourself by a family member  
 
14 % (161) 
 
27 % (246) 
 
<. 001 
Being physically hurt or attacked 
by a non-family member 
 
18 % (202) 
 
21 % (188) 
 
  ns 
Sexual assault  14 % (157) 18 % (161) <. 02 
PTSD symptom diagnosis 
  Full 
  Partial 
 
22 % (253) 
12 % (136) 
 
5 %  (42) 
8 %  (74) 
 
<. 001 
<. 01 
   statistic = chi-squared  
   ns = not statistically significant 
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TABLE 3:  Trauma Exposure by Gender  
 
        S.A.  
      (n=1021) 
         KENYA 
        (n-887) 
 
Common Trauma Types 
 Girls 
%(count) 
Boys 
%(count)
p  
 
Girls 
%(count) 
Boys 
%(count) 
  p 
 
 
Exposure to ≥ 1 trauma 
 
82 (472) 
 
84 (371) 
 
ns 
 
83 (429) 
 
87 (324) 
 
  ns 
Witnessing violence in the 
street, neighbourhood, or 
school 
 
55 (321) 
 
60 (265) 
 
ns 
 
64  (330) 
 
75  (278) 
 
<. 001 
 
Being robbed or mugged  
 
33 (190) 
 
37 (162) 
 
ns 
 
34  (174) 
 
41  (151) 
 
<. 02 
 
Being in a bad accident 
 
24 (140) 
 
28 (123) 
 
ns 
 
15  (76) 
 
17  (61) 
  
  ns 
Being in an earthquake, 
fire, flood, or other 
natural disasters 
 
15 (87) 
 
17 (74) 
 
ns 
 
15  (76) 
 
16  (60) 
 
  ns 
Seeing family members 
injured, beaten, hurt, or 
killed  
 
32 (185) 
 
33 (145) 
 
ns 
 
35  (182) 
 
28  (102)
 
<. 02 
Being beaten or physically 
hurt yourself by a family 
member 
 
12 (71) 
 
15 (67) 
 
ns 
 
27  (136) 
 
29  (107) 
 
  ns 
Being physically hurt or 
attacked by a non-family 
member 
 
16 (93) 
 
20 (88) 
  
ns 
 
13  (65) 
 
33  (121)  
 
<. 001 
 
Sexual assault 
 
12 (72) 
 
15 (64) 
 
ns
 
14  (71) 
 
24  (87) 
 
<. 001 
 
‘missing’ gender:  South Africa n=119, Kenya  n=14 
statistic = chi-square 
ns = not statistically significant 
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TABLE 4: PTSD, Depression by Gender  
 
      S.A.  (n=1021)      KENYA (n=887)  
Symptom 
Profile 
Girls 
(n=579) 
Boys  
(n=442) 
p 
 
Girls  
(n=515) 
Boys 
(n=372) 
P 
Intrusive 
symptoms 
 Mean (SD)      
 
1.6 (2.1) 
 
1.2 (1.9) 
 
<.003
 
0.6  (1.3) 
 
0.5 (1.3) 
 
 ns 
Avoidance 
symptoms        
 Mean (SD)      
 
2.2 (2.3) 
 
1.9 (2.1) 
 
<.02 
 
1.2  (1.4) 
 
1.1 (1.3) 
 
 ns 
Hyperarousal 
symptoms     
  mean  (SD) 
 
1.7 (2.1) 
 
1.5 (2.0) 
 
 ns 
 
0.5  (0.9) 
 
0.5 (0.9) 
 
 ns 
No. of PTSD 
symptoms 
  mean  (SD) 
 
4.7 (5.4) 
 
5.1 (5.5) 
 
 ns 
 
2.3  (2.9) 
 
2.2 (2.9) 
 
 ns 
Full PTSD 
symptoms  
  N (%) 
 
122 (21) 
 
107 (24) 
 
 ns 
 
26   (5) 
 
16  (4) 
 
 ns 
Partial PTSD 
symptoms     
  N (%) 
   
68  (12) 
 
57   13) 
  
 ns 
 
43   (8) 
 
28  (8) 
 
 ns 
Depressive 
symptoms        
  mean  (SD) 
 
10.7(10.4) 
 
11.7(10.7) 
  
 ns 
 
12.4 (9.3) 
 
9.5 (7.9) 
 
<.0001 
missing gender:  South Africa n=119, Kenya  n=14 
ns = not statistically significant   
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TABLE 5: Lifetime Trauma Exposure & PTSD Symptom Diagnosis   
    by Ethnicity                    
 
 
Ethnicity 
Lifetime Trauma Exposure 
 
S.A.              Kenya 
 %  (count)      %  (count)  
PTSD with Lifetime Exposure 
 
S.A.                 Kenya 
 %  (count)       %  (count)
 
Asian  
 
86% (19/22)       60% (3/5) 
 
21% (6/19)         0% (0/5) 
 
Black 
 
75% (166/221)     85% (734/867) 
 
27% (56/166)       5% (40/734) 
Mixed 
Descent 
 
85% (371/437)        ----- 
 
25% (108/371)       ----- 
 
White 
 
86% (285/333)    100% (3/3) 
 
20% (58/285)       0% (0/3) 
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3.  EPIDEMIOLOGY AND PHENOMENOLOGY OF POSTTRAUMATIC  
    STRESS DISORDER IN A CLINIC SAMPLE 
 
Clinical Correlates, Differential Symptom Patterns and 
Gender Differences in Traumatised Adolescents With and 
Without Posttraumatic Stress Disorder 
 
3.1 Study Summary  
Few studies have focused on the assessment of full and 
partial PTSD in trauma-exposed adolescents in clinic 
settings. This study examined the prevalence of violence 
exposure and PTSD, clinical and functional aspects of full/ 
subsyndromal forms of the disorder and gender differences 
in a sample of treatment-seeking adolescents exposed to at 
least one PTSD-qualifying event. 
 
170 consecutively referred adolescents (58% female) with a 
mean age of 13.8 years (SD=2.9 years) completed an 
assessment battery comprising a clinician-administered 
diagnostic interview (Kiddie-Schedule for Affective 
Disorders and Schizophrenia [K-SADS]) and several self-
report measures of community violence exposure, childhood 
abuse, and PTSD symptom severity. 
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More than half the sample had been exposed to at least 
three traumatic events, with the commonest index traumas 
reported being witness to serious domestic violence (48.2%) 
and sexual abuse (45.9%). 47% met criteria for full PTSD 
while a further 19% met partial symptom criteria. Of note, 
no significant differences were observed in adolescents 
with full or subsyndromal forms, either in symptom 
persistence (duration of PTSD) or in school, family, or 
social impairment. Adolescents with full PTSD were 
significantly more likely to be depressed than those with 
partial PTSD or no disorder. While no gender differences in 
the rate of trauma exposure or PTSD (full and partial) were 
observed, girls suffered more severe childhood abuse, 
community violence, and exposure to negative life events.  
 
These data support the utility of assessing for partial 
PTSD in traumatised adolescents who, despite exhibiting 
fewer PTSD symptoms, may experience significant impairment 
and distress. 
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3.2 Background 
Several lines of evidence suggest that treatment-seeking 
children and adolescents exposed to various traumatic 
events have far higher prevalence rates of PTSD than 
general population samples, ranging from 15% to more than 
90% (Pfefferbaum, 1997, review). More importantly, clinic 
referred adolescents compared with community sampled 
adolescents may be two times more likely to report a 
traumatic event and, depending on the index trauma, 25 
times more likely to report symptoms of posttraumatic 
stress (Costello et al., 1998). While studies among adults 
suggest that approximately 25% of individuals exposed to 
trauma develop symptoms of PTSD (Breslau et al., 1991; 
Green, 1994, review), the situation differs somewhat in 
children and adolescents where many factors (e.g., trauma 
severity, time lapsed since the trauma, and definition of 
outcome) may produce greater variability in estimates (Pine 
and Cohen, 2002, review).  For example, in a study of 
school-age children from three cities at increasing 
distances from the epicenter of the 1988 Armenian 
earthquake, rates of PTSD-like reactions in those living 
closest to the epicenter exceeded 90% (Goenjian et al., 
1995).  Much lower rates have been documented in children 
exposed to less extreme and relatively brief stressors, 
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particularly if some time has lapsed since the trauma (Laor 
et al., 2001; Keppel-Bendson et al., 2002; Zink and McCain, 
2003).   
 
In a study that was conducted at an inner-city child and 
adolescent psychiatry clinic, 27% of children and 
adolescents exposed to a PTSD qualifying trauma 
(principally physical abuse, sexual abuse and witnessing 
domestic violence) met criteria for a diagnosis of PTSD, 
while a further 32% had partial or subthreshold 
symptomatology (Silva et al., 2000). Identification of 
symptoms of posttraumatic stress and other psychopathology 
in traumatised adolescents who present to primary, 
secondary and tertiary health care settings may lead to 
timely psychiatric intervention, at a critical transitional 
stage into adulthood (Lipschitz et al., 2000). However, the 
evaluation and assessment presents a constellation of 
complex and unique challenges, in part owing to ongoing 
developmental issues in this group. The nature of the 
stress-inducing event and the adolescent’s subjective 
experience of a traumatic event are both influential 
factors in PTSD symptom expression (Drake et al., 2001).   
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The 4th edition of the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV) (APA, 1994) was notable for its 
revision of the stressor criterion from a traumatic event 
that is outside the range of usual human experience and 
would be markedly distressing to almost anyone, to a 
traumatic event that involves actual or threatened death or 
serious injury and incites a response of intense fear, 
horror, or helplessness. This criterion recognises that in 
many locations around the world (including South Africa) 
violence is endemic, such that traumatic events cannot be 
considered as outside of the range of usual human 
experience.  
 
That said, while there is a rich body of literature on 
community-related precipitating events (e.g., school 
shootings, bombings, physical assault, war) for PTSD and 
other psychopathology, the literature focusing on the 
assessment of trauma-exposed children and adolescents with 
and without PTSD, in clinical contexts, is somewhat 
limited. The current analysis was undertaken to supplement 
previous findings of trauma and PTSD characteristics in a 
community sample by examining a clinic sample of 
adolescents. It was envisaged that evaluation of this 
population using a structured, psychometrically sound, 
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clinician-administered diagnostic interview (in addition to 
adolescent self report measures used in the community 
survey) would provide more extensive data on diagnostic 
morbidity and comorbidity, and more careful delineation of 
the nature of trauma/ violence exposure, full and partial 
PTSD symptoms (and other psychopathology) and gender 
effects. It would also provide some means of comparison of 
demographic and phenomenological differences in clinic-
based and community-based adolescents and would serve to 
clarify whether PTSD symptom cluster profiles in trauma-
exposed adolescent clinic attendees (i.e., a potentially 
‘high-risk’ sample) differ significantly from trauma-
exposed community-based adolescents (i.e., a potentially 
‘low- risk’ sample).        
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3.3 Methods 
 
3.3.1 Subjects 
Consecutive referrals who presented to the Bathuthuzele 
Youth Stress Clinic at the MRC Research Unit on Anxiety and 
Stress Disorders (Department of Psychiatry, University of 
Stellenbosch, Tygerberg) were included in the analysis. The 
clinic offers a screening evaluation, assessment, 
medication, and referral service for traumatised 
adolescents. A research psychologist conducted initial 
telephonic screening interviews with prospective subjects 
to identify individuals who had experienced a traumatic 
event meeting the A1 criterion for PTSD (APA, 1994).  The 
study was approved by the University of Stellenbosch ethics 
committee. Prior to the administration of study procedures, 
written informed consent for participation was obtained 
from parents or legal guardians in addition to written 
assent being obtained from adolescents.  
 
The study sample comprised 170 adolescents (n=170), with a 
mean age of 13.75 years (standard deviation (SD)=2.9 years, 
range: 10 to 18 years). There were 99 females (58%) and 71 
males (42%) and the majority (78.8%) were of mixed race 
(Table 1).  
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3.3.2 Procedures 
Participants were administered an assessment battery by a 
clinical psychologist which included a demographics 
questionnaire (as used in chapter 2), a clinician-
administered diagnostic interview (Kiddie Schedule for 
Affective Disorders and Schizophrenia [K-SADS]) (Kaufman et 
al., 1997) and self-report measures of PTSD, depression and 
other psychopathology, violence exposure and childhood 
trauma.  
 
3.3.3 Instruments 
(i) The Kiddie-Schedule for Affective Disorders and 
Schizophrenia (K-SADS-PL)-Present and Lifetime version  
The K-SADS-PL (Kaufman et al., 1997) was used to evaluate 
for the presence of psychiatric diagnoses (current and 
lifetime), and as the ‘gold standard’ for the diagnosis of 
PTSD. The K-SADS-PL includes an initial 82-item screen 
interview that surveys key symptoms for current and past 
episodes in 20 different diagnostic areas, skip-out 
criteria that determine whether additional interviewing is 
necessary, and supplemental diagnostic sections to be 
completed, as indicated (Kaufman et al., 2000). The screen 
interview is initially administered and based on the 
results of the screen interview, the interviewer moves on 
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to five diagnostic supplements, which include affective 
disorders, anxiety disorders, psychotic disorders, 
behavioural disorders, substance abuse, tic and eating 
disorders covered in the DSM-IV (APA, 1994). Thus, detailed 
symptomatic data are not obtained in non-diagnosed 
disorders because of the extensive use of symptom “skip-
outs” (Ambrosini, 2000). The interview takes approximately 
45-75 minutes to conduct, and is administered to both 
parent/guardian and child. The K-SADS-PL has been shown to 
have excellent interrater reliability and concurrent 
validity (Ambrosini, 2000). It is arguably the primary 
diagnostic manual in use for the assessment of DSM-IV 
diagnoses.    
(ii) Child PTSD Checklist 
The Child PTSD Checklist (Newman and Amaya-Jackson, 1996), 
a 28-item symptom status measure of PTSD, has been 
described in chapter 2. For this study, as in other studies 
(Lipschitz et al., 2000), DSM-IV symptom criteria (minimum 
of 1 re-experiencing, 3 avoidance, 2 hyperarousal symptoms) 
were applied to determine the number of PTSD cases (based 
on symptom criteria alone).  
(iii) Child Exposure to Violence Checklist (CEVC) 
The CEVC (Amaya-Jackson, 1998) is a self-report, 33 item 
checklist adapted from Richters and Martinez’s “Things I’ve 
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Seen and Heard” (Richters, 1990). It assesses various types 
of violence that may have been experienced, witnessed or 
heard about. Examples of violence rated include shootings, 
stabbings, sexual assault, and family violence. Responses 
are coded on a 5-point Likert scale ranging from “never” to 
“more than 10 times”. Total scores are obtained with higher 
scores indicating higher levels of violence exposure. 
Although there is limited published psychometric 
information on this survey, it has been shown to have good 
internal consistency with coefficient alphas ranging from 
.51 to .90 for each violence category (Fehon et al., 2001). 
In a subgroup of 31 inpatients, the kappa coefficients for 
agreement ranged from .47 to .85 for the different 
categories of violence.  
(iv) Beck Depresssion Inventory (BDI) 
The BDI (Beck et al., 1961) is a 21-item self-report scale 
(described in chapter 2). A total score for the 21 items 
was obtained, with higher scores indicating more depressive 
symptoms.  
(v) Childhood Trauma Questionnaire (CTQ) 
The CTQ (Bernstein and Fink, 1998), a 28-item measure that 
assesses five domains of childhood abuse and neglect:  
physical abuse, sexual abuse, emotional abuse, physical 
neglect and emotional neglect, was used as the primary 
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measure of childhood trauma severity. The reliability of 5 
CTQ subscales range from 0.66 to 0.92 in psychiatric 
outpatients, and content, concurrent, and construct 
validity have been established. While it was originally 
developed for adults, various modifications have been made 
for use down to 12 years of age and it reportedly functions 
as well with adolescents as it does with adults (Ohan et 
al., 2002).  
(vi) Life Events Questionnaire for Adolescents (LEQ-A) 
The LEQ-A (Masten et al., 1994), as described in chapter 2, 
is a 45-item measure of negative and positive life events. 
It was used in the study to measure non-PTSD events. These 
events, while defined as psychologically challenging, are 
generally distinguishable from PTSD-defined traumatic 
events by their lesser intensity. The LEQ-A was developed 
by Project Competence at the University of Minnesota. The 
negative life event items in the scale were summed to 
compute a total score for negative life events experienced 
by adolescents in the past year.   
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3.4 Statistical Analyses 
Statistical analysis, using SPSS software version 11.0, 
proceeded from descriptive statistics to a series of 
univariate and multivariate analyses to examine the 
relationship among demographic, trauma exposure, and 
clinical characteristics. The analyses focused on current 
rather than lifetime PTSD, to be consistent with the 
assessments and analyses that were conducted in the 
community sample (Chapter 2). Adolescents with exposure to 
traumatic events were assigned to one of 3 outcome groups 
(i) those without any symptoms of PTSD (ii) those with 
subthreshold PTSD and (iii) those who met full criteria for 
PTSD. Demographic and psychopathological differences were 
assessed among the groups using a series of x2 tests and 
one-way analyses of variance with Tukey post hoc 
comparisons. Chi-square and student’s t-tests were used to 
compare boys and girls in the sample. All tests were 2-
tailed with significance set at p < 0.05, unless otherwise 
specified.  
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3.5 Results 
3.5.1 Demographic characteristics  
Table 1 shows the demographic characteristics of the total 
sample and the distribution by gender. Girls were 
significantly older than boys (mean age ± SD in years for 
boys: 12.6 ± 2.8, for girls: 14.6 ± 14.6, t= -4.7, df=168, 
p<0.001) and girls were also more likely than boys to be in 
a higher grade at school (28 boys vs. 63 girls were in 
grades 7 to 12, Fisher’s Exact Test (FET), p <0.003). There 
were no significant gender differences with respect to 
substance use (cigarette smoking, alcohol and cannabis) and 
also no differences between the groups (boys/girls) with 
respect to parents’ marital, living or employment status.  
 
3.5.2 Pattern of trauma exposure 
Tables 2 and 3 illustrate the pattern of exposure by trauma 
type, frequency of occurrence, and age of onset. More than 
half the sample (55.3%) was assessed on the K-SADS as   
having had lifetime exposure to at least three PTSD 
qualifying traumas (Table 3). The commonest traumatic 
events reported were, in order of frequency: (i) being a 
witness to serious domestic violence (48.2%), (ii) sexual 
abuse (45.9%), (iii) being confronted with extremely 
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traumatic news (42.4%), witnessing a violent crime (41.2%), 
and (v) being a victim of a violent crime (25.9%).   
 
3.5.3 PTSD diagnosis, Partial PTSD & PTSD symptoms 
47.1 % of adolescents (n=80) met criteria for a current 
diagnosis of PTSD on the K-SADS and 33.1 % met criteria for 
a lifetime diagnosis. 19.4% (n=33) met criteria for a 
current partial/subthreshold diagnosis (Table 3) while 
22.9% (n=39) had neither the full nor partial syndrome 
(i.e., did not fulfil criteria of at least 1 re-
experiencing, 1avoidance, and 1 hyperarousal symptom). 
Adolescents who met criteria for full PTSD endorsed 
significantly more symptoms from criteria sets B, C, and D 
compared with those who had a subthreshold syndrome (Table 
4).  
 
Table 5 outlines the percentage of adolescents in the 
sample who endorsed each of DSM-IV based symptoms for PTSD 
(K-SADS). The most commonly endorsed symptoms were, in 
descending order, efforts to avoid thoughts or feelings and 
activities/places linked to the events (53.2%), exaggerated 
startle responses (52.7%), hypervigilance (51.1%), 
difficulty concentrating (51.1%) and insomnia (49.5%).  
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There were no significant differences between those with 
full PTSD and those with partial PTSD with respect to the 
rate at which impairments in school functioning (FET, p 
<1.00), social functioning (FET, p < .84) and family 
functioning (FET, p < .52) were endorsed. Although 
adolescents with full PTSD tended to have a longer duration 
of symptoms (current episode) than those with the 
subthreshold form, differences between the 2 groups did not 
reach statistical significance (full PTSD vs. partial PTSD 
= 6.9 ± 18.4 vs. 4.6 ± 12.0, t = -0.63, p = 0.45). 
 
3.5.4 PTSD caseness: Agreement between clinician-
administered & self-report measures  
Caseness for PTSD in the study was determined from three 
sources: (i) the K-SADS (the primary diagnostic measure), 
(ii) the Child PTSD Checklist, and (iii) a clinician-based 
PTSD diagnosis. Clinicians, following administration of the 
K-SADS, were also asked to say whether based on their 
clinical judgment alone they would consider making a PTSD 
diagnosis. Using this method, clinicians documented a 
diagnosis of PTSD in 56.5% of adolescents (n=96, missing: 
N=13). The rate of PTSD was also computed on the self-
report Child PTSD Checklist by applying DSM-IV symptom 
criteria (minus the ‘clinically significant 
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distress/impairment’ criterion which is not measured by the 
checklist). This measure yielded a PTSD rate of 34.7% 
(n=59).  
 
To achieve consistency with a symptom-based diagnosis of 
PTSD on the Child PTSD Checklist, identical criteria were 
then applied to the K-SADS (i.e., the presence of 1 
intrusive, 3 avoidance, 2 hyperarousal symptoms in the 
absence of the ‘functional impairment/distress’ criterion) 
to compute a separate PTSD ‘symptom diagnosis’. This 
yielded an almost identical rate (47.6%, n=81) to when 
routine criteria were applied.  
 
Chi-square tests were then used to determine if there was a 
significant difference in PTSD diagnosis between the K-SADS 
and Child PTSD Checklist. Cohen’s kappa coefficients 
(Cohen, 1960) were also used to assess the level of 
agreement. The level of agreement between the measures was 
only 60%:  60% of PTSD cases were correctly diagnosed on 
both measures (kappa=. 21, p = .006). However, 24% were 
misclassified with PTSD on Child PTSD Checklist, while 54% 
of adolescents who received a diagnosis of PTSD on the K-
SADS were not classified as such on the Child PTSD 
Checklist. The level of agreement was higher between 
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clinician assessments of PTSD and the K-SADS (76%, kappa 
=.51, p = 0.000).   
 
3.5.5 Trauma type & PTSD risk 
Contrary to expectation, no significant associations were 
found between the type of trauma (on the K-SADS Traumatic 
Events screen) and the risk for PTSD (K-SADS), using 
Pearson chi-square and odds ratio calculations. Similarly 
no significant association emerged when the sample was 
stratified by gender. 
 
3.5.6  Trauma exposure, PTSD & ethnicity  
With respect to ethnic differences, 63.6% of White 
adolescents, 52.2% of Coloured adolescents, and 77% of 
Black adolescents reported lifetime exposure to at least 3 
traumas. The low number of White respondents in the sample 
precluded meaningful comparisons. Preliminary analysis 
revealed no significant differences in the number of 
traumatic event exposures (grouped as those with <3 
lifetime exposures and those with ≥3 lifetime exposures) 
between White and non-White adolescents (FET, p=0.76) and 
also no difference among the 3 groups (Black, mixed 
ethnicity, White) (x2=5.1, df=2, p < 0.08).  
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44% of White adolescents, 54% of mixed race adolescents and 
47% of Black adolescents met K-SADS PTSD criteria. Again, 
there appeared to be no significant difference in the rate 
of PTSD caseness between White and non-White adolescents 
(FET, p=0. 74) and no difference among the 3 groups (x2=0.6, 
df=2, p =0.76). 
  
3.5.7 Other diagnoses on the K-SADS 
The most common K-SADS ‘current’ diagnoses (occurring at a 
frequency of ≥5% in the sample) were: major depressive 
disorder (MDD) (20 %), acute stress disorder (ASD) (19%), 
enuresis (12%), specific phobia (8%), oppositional defiant 
disorder (ODD) (7%) and attention deficit/hyperactivity 
disorder (ADHD) (5%) (Table 6). Four adolescents also met 
criteria for a lifetime diagnosis of MDD. Among adolescents 
with current MDD, 11 (32%) reported current suicidal 
ideation while 8 adolescents (24%) endorsed past suicidal 
ideation. Five (15%) had committed suicidal acts in the 
past. Other disorders occurring at a slightly lower 
frequency included panic disorder (4%), generalised anxiety 
disorder (3%), alcohol abuse (2.9%) and dysthymic disorder 
(2%).  
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Chi-square tests were conducted to determine 
psychopathological differences (using diagnoses that 
occurred at ≥5% frequency in the sample) among adolescents 
with full PTSD, adolescents with partial PTSD, and 
adolescents with no PTSD. Adolescents with full PTSD were 
significantly more likely to be depressed (i.e., to have 
comorbid MDD) compared with the other two groups: 79% of 
adolescents with full PTSD also met criteria for depression 
compared with 4% of adolescents with partial PTSD, and 17% 
with no PTSD, x2 = 7.2, p <0.03).  As noted in Table 6, with 
the exception of specific phobia, all other co-occurring 
disorders in the sample were most likely of post-traumatic 
onset, and either concurrent with or proceeding the onset 
of PTSD.  
 
 
3.5.8 Gender & trauma exposure  
There were no gender differences in the number of exposures 
(lifetime) to PTSD-qualifying traumatic events (Table 3). 
Girls had significantly higher rates of sexual abuse than 
boys (63.9% vs. 23.5%), FET, p <0.001). However, there were 
no significant gender differences in the rate of exposure 
to other PTSD qualifying traumas including being a victim 
of physical abuse or being a victim/witness to violent 
crime (Table 3). 
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3.5.9  Gender, PTSD diagnosis & PTSD symptom clusters 
Boys and girls had similar rates of current full PTSD (K-
SADS diagnosis) (53.5% vs. 51.5% respectively, FET,  
p < 0.88) and current subthreshold/partial PTSD (21.2% vs. 
21.8% respectively, FET, p < 1.00). There were also no 
significant differences in the rate of full PTSD when a 
clinician-based diagnosis of PTSD (instead of a diagnosis 
on the K-SADS) was subjected to chi-square analysis (FET,  
p < .42). With respect to specific PTSD symptoms as 
elicited on the K-SADS, girls were significantly more 
likely to endorse symptoms of (i) irritability (63.3% vs. 
44.8%) and (ii) detachment/numbing (54.9% vs. 45.4%) than 
boys (Table 5). Girls were also significantly more likely 
than boys to report clinically significant interference 
from PTSD symptoms in current social (51% of girls vs. 32% 
of boys, FET, p = 0.04) and family domains (58% of girls 
vs. 37% of boys, FET, p <0.046).    
 
In the sample (irrespective of PTSD diagnosis), there were 
no significant gender differences in the mean number of 
intrusive symptoms (boys vs. girls 2.2 ± 1.6 vs. 2.4 ± 1.5, 
t =-0.75, df=144, p <0.46), avoidance symptoms (boys vs. 
girls: 3.2 ± 2.1 vs. 3.4 ± 1.7, t= -0.83, df=146, p <0.42), 
or hyperarousal symptoms (boys vs. girls: 2.7 ± 1.8 vs. 3.1 
  
116
± 1.8, t=-1.22, df = 151, p < 0.23) on the K-SADS. However, 
a different picture emerged on the Child PTSD Checklist, 
where girls endorsed significantly more PTSD symptoms 
overall (indicative of greater PTSD severity) and also more 
symptoms in each symptom domain (re-experiencing, 
avoidance, hyperarousal) (Table 7).       
 
3.5.10   Gender & comorbidity 
Girls were significantly more likely than boys to meet 
criteria for MDD (79% of adolescents who fulfilled MDD 
criteria were girls vs. 21% who were boys, x2 = 6.5, p < 
0.02) but not for the other disorders examined (ASD, ADHD, 
ODD, enuresis, specific phobia). The mean number of K-SADS 
diagnoses in the sample was 1.2 ± 1.3 (range 0 to 7) and 
there were no significant gender differences in the number 
of co-occurring disorders (Table 6).  
 
 
3.5.11 Gender & childhood trauma 
As a group, females reported significantly higher levels of 
childhood trauma (CTQ total and on all 5 clinical scales). 
Gender differences were especially significant for sexual 
and emotional abuse (Table 7). Scores in these 2 clinical 
domains were suggestive of moderate to severe levels of 
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sexual abuse and low to moderate levels of emotional abuse 
in the female group (Bernstein and Fink, 1998). 
 
3.5.12 Gender & negative life events 
On the LEQ-A, the mean number of negative life events 
reported overall was 8.4 ± 5.8 (range 0 to 33) (Table 7), 
with girls reporting significant more mean negative life 
event exposures in the past year than boys (9.2 ± 6.6 vs. 
7.3 ± 4.5, t= -2.23, df=168, p < 0.03). 
 
3.5.13 Gender & depressive symptoms 
On the self-report BDI, although girls endorsed higher 
levels of depressive symptoms than boys (mean ± SD: 23.3 ± 
13.9 vs. 9.8 ± 11.9), this did not reach significance (p < 
0.07) (Table 7). 
 
3.5.14 Correlation of PTSD symptoms with other self-report     
measures 
Scores on the Child PTSD checklist were positively 
correlated with exposure to community violence (CECV) (r = 
.45, p < 0.001), exposure to childhood trauma (CTQ) (r = 
.55, p < 001), exposure to negative life events (r = .36, p 
<0.001), and depressive symptoms (r = .46, p < .05) 
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Statistical significance for all of these variables was 
maintained in the analysis by gender. With respect to the 
relationship between CTQ and LEQ-A scores, a stronger 
positive relationship was found within the male group (r = 
0.64, p < 0.001) compared with the female group (r =0.45, p 
< 0.001). 
 
3.5.15  PTSD versus non-PTSD groups 
In comparing PTSD (N=80) and non-PTSD (N=72) groups 
respectively, there were no significant differences in 
demographic characteristics: mean age (14.0 ± 3.2 vs.  
13.2 ± 2.7 years, t= -1.6, df=150, p < 0.12); gender (58% 
female vs.56% female, FET, p< .88); ethnicity (95% non-
White vs.93% non-White). There were also no significant 
differences between adolescents with and without PTSD with 
respect to personal psychoactive substance use (nicotine, 
alcohol, cannabis), family characteristics (e.g. parental 
marital status/ employment/substance use). However, as 
mentioned above, there was a significant difference in the 
rate of major depression among the groups. Table 8 compares 
some of the clinical correlates of PTSD (total number of 
PTSD traumatic events and CECV, CTQ, LEQ-A scores) in 
adolescents with full, partial, and no PTSD. No significant 
differences in these measures were observed across the 
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groups and there were also no significant differences when 
the sample was stratified by gender. 
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3.6 Discussion 
3.6.1 Rates of trauma & PTSD 
These results demonstrate that the vast majority of 
treatment-seeking adolescents in the sample had multiple 
exposures to PTSD-qualifying traumatic events (including 
community and domestic violence). Severity of exposure to 
one type of trauma (e.g. community violence) was highly 
correlated with severity of exposure to other types of 
trauma (e.g. childhood abuse). The commonest traumatic 
events reported were, in order of frequency: being a 
witness to serious domestic violence, sexual abuse, being 
confronted with extremely traumatic news, and being witness 
to a violent crime. Witnessing serious domestic violence, 
the commonest type of trauma documented here, is known to 
be associated with increasing morbidity in children and 
adolescents and may be an especially potent factor in the 
development of PTSD (Silva et al., 2000). It has also been 
shown to be a common index event for PTSD in other studies. 
For example, in a clinic study of traumatised adolescent 
girls (Lipschitz et al., 2000), witnessing domestic 
violence was reported as one of the “most distressing or 
upsetting” index events.  
 
  
121
It is notable that traumatic experiences (including sexual 
assault) did not differ in their association with the 
development of PTSD in this sample. Sexual assault, in 
particular, has been shown to be associated with a high 
risk for PTSD (Breslau et al., 1991; Giaconia et al., 
1995), however, the lack of a significant association in 
this population who were multiply traumatised and presented 
with compounded community and domestic trauma suggests 
perhaps that, in this context, sexual assault may have a 
high likelihood of co-occurrence with other factors. Thus, 
sexual assault per se was not significantly related to PTSD 
but may have worked synergistically with other traumatic 
events to give rise disorder. 
 
3.6.2  Full versus Partial PTSD 
47% of traumatised adolescents met full DSM-IV criteria for 
PTSD while a further 19% met partial criteria. These rates, 
both of full PTSD and partial PTSD, are considerably higher 
than those reported in other clinic/ hospital adolescent 
samples (in the range of 11 to 24%). For example, one study 
of female adolescent clinic attendees found that 14.4 % and 
11.6% of traumatised girls met criteria for full and 
partial PTSD, respectively (Lipschitz et al., 2000), while 
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in another study of youth hospitalised for accidental 
injuries (7 to 17 years), full PTSD was documented in  
12.5 % and partial symptoms in a further 16.7% (Daviss et 
al., 2000). In a more recent sample of clinic-referred 
youth (7 to 14 years of age) with histories of trauma, the 
rate of full PTSD (as measured on the Clinician-
Administered PTSD Scale for Children and Adolescents) was 
24% (Carrion et al., 2002). 
 
It is perhaps notable that the rates of full and partial 
PTSD were high even when other methods of determination 
were used (viz., the Child PTSD Checklist and clinician 
assessment). The 19% rate of partial PTSD is higher than 
expected considering the relatively strict definition of 
partial PTSD compared with other studies (Giaconia et al., 
1995; Stein et al., 1997, Lipschitz et al., 2000). Only one 
study has documented a higher rate of partial PTSD (32%) in 
a similar sample (i.e., traumatised adolescent clinic 
cohort) (Silva et al., 2000). The high rates in this study 
may, in part, be a reflection the relatively stringent 
admission criteria to our clinic. The clinic is located 
within a tertiary academic centre and only recruits 
traumatised adolescents who are presumed, at screening, to 
have emotional and/or behavioural problems. It is, 
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therefore, likely that only the most symptomatic 
adolescents are referred for evaluation.  
 
3.6.3 Comorbidity 
In comparing the groups (full PTSD, partial PTSD, no PTSD), 
the only significant difference that emerged was in the 
rate of major depression; adolescents with full PTSD were 
far more likely than those with the subthreshold syndrome 
or no syndrome to be depressed. Higher rates of major 
depressive disorder have consistently been documented in 
individuals with PTSD. For example, Giaconia and colleagues 
(1995) reported that more than 41% of adolescents with PTSD 
met criteria for major depression by the age of eighteen, 
compared with 8% of those without PTSD. Physically and 
sexually maltreated youth with PTSD have similarly 
demonstrated significantly more mood and anxiety 
comorbidity than maltreated youth without PTSD (Linning and 
Kearney, 2004). Furthermore, differences in clinical 
presentation have been documented in youth with PTSD (with 
and without comorbidity). In a study comparing abused 
children with PTSD, nonabused children with PTSD and 
concurrent MDD, and nonabused children with MDD only 
(Runyon et al., 2002), those children with both disorders 
were more likely to report flashbacks and difficulty 
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sleeping while those with PTSD-only tended to experience 
more episodes of psychological amnesia. It has been 
suggested that youth with both disorders may be less likely 
to mentally avoid their emotional distress which, in turn, 
may lead to an increase in feeling out of control and 
flashbacks (Runyon et al., 2002). Not all studies have 
found higher rates of concurrent depression in adolescent 
PTSD. Silva et al. (2000) found similar rates of 
comorbidity, with the exception of disruptive behaviour 
disorders (oppositional defiant disorder and conduct 
disorder) which were more frequently observed in the 
subthreshold and non-PTSD groups.   
 
With regard to comorbid substance use, few adolescents met 
criteria for a substance use disorder on the K-SADS. This 
may partly reflect recruitment bias as adolescents with 
comorbid substance use disorders are more likely to be 
referred within the tertiary hospital setting directly to 
child psychiatry services. That said, the co-occurrence of 
PTSD and substance use disorders has been fairly 
extensively documented in both adolescents (Simkin, 2002, 
review) and adults (Brady et al., 2000, review). For 
example, a recent study comparing traumatised, inner-city 
adolescent girls with and without PTSD (Lipschitz et al., 
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2003), found that both those with full PTSD and partial 
PTSD were more likely to use nicotine, cannabis, and/or 
alcohol on a regular basis than those without.  In fact, it 
has been suggested that the association between PTSD and 
substance use may be especially salient for girls. 
Lipschitz et al. (2000) found that PTSD symptoms were 
significantly associated with problematic drug and alcohol 
use in girls but not in boys.  
 
3.6.4 Clinical & functional correlates  
The three groups (full PTSD, partial PTSD, no PTSD) were 
not discriminated on the mean number of PTSD-related 
events, level of child abuse, degree of exposure to 
community violence, or negative life experience. In 
contrast, one study has reported higher levels of prior 
psychopathology, higher parental acute distress and higher 
rates of prior sexual abuse in adolescents with the full 
syndrome compared with those who had partial PTSD or no 
disorder (Daviss et al., 2000).  It is arguable that the 
failure to detect group differences in this study relates 
to sample size (i.e., there were relatively small numbers 
within each group). Despite this, an important finding 
emerged: adolescents with subthreshold syndrome were not 
significantly different from children meeting full criteria 
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when the level of impairment in key areas of functioning 
(school, social, and family) was looked at. Of note, too, 
was the absence of a group difference with respect to PTSD 
symptom duration, suggesting that symptom persistence and 
rate of functional interference may not be too dissimilar 
across these syndromes. This supports the work of Carrion 
et al. (2002) who suggested that impairment in PTSD might 
be attributable to the effects of PTSD symptoms rather than 
to other clinical characteristics. In adolescents with full 
and partial PTSD, the most commonly occurring PTSD symptom 
endorsed was ‘avoidance of thoughts, feelings, and 
conversations associated with the trauma’. Interestingly, 
this symptom has been documented as being one of the most 
frequently occurring manifestations in adolescents with 
PTSD in several studies (Lipschitz et al., 2000; Carrion et 
al., 2002; Cuffe et al., 1998).  
 
3.6.5 Gender effects for trauma & PTSD 
Also notable, were lack of gender differences in the rate 
of exposure to trauma and in the rates of PTSD (full and 
subthreshold). With the exception of sexual assault (which 
was more prevalent in girls), there were no gender 
differences with respect to other types of exposure, 
including physical assault. This is contrary to what was 
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hypothesised in the study, namely, that boys would be more 
likely to endorse higher levels of violence exposure, in 
particular physical assault. As noted in an earlier 
chapter, some community-based studies have noted a greater 
incidence of trauma in adolescent/young adult males 
(Breslau et al., 1991; Norris, 1992; Vrana and Lauterbach, 
1994) while others have found few gender differences in 
rates of specific traumas (Giaconia et al., 1995). 
Consistent with the higher rate of sexual assault in girls, 
girls compared with boys endorsed more childhood abuse 
(including childhood sexual assault) and, in fact, gender 
differences for sexual and emotional abuse were highly 
significant on the CTQ. This is in keeping with the 
findings of a validation study of the CTQ in an adolescent 
population (12-17 years of age), where girls scored higher 
on sexual and emotional abuse subscales (Bernstein et al., 
1997). Fehon et al. (2001) also reported significantly 
higher mean levels of childhood trauma on the CTQ in 
adolescent girls compared with boys. Further, it has been 
suggested that the CTQ may have a lower threshold for 
detection of sexual abuse, particularly in boys but this 
warrants further study (Lipschitz et al., 1999). 
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With respect to gender specificity in PTSD, very few 
clinic-based paediatric studies have examined or found 
gender differences. For example, in one study of 
hospitalised adolescents (Fehon et al., 2001a), those with 
PTSD were more likely to be female. Higher rates of PTSD in 
girls were confirmed in a follow-up study by the same 
authors (Fehon et al., 2001b). However, in the 
aforementioned study girls with PTSD could not be 
differentiated from boys on other socio-demographic 
variables, for example age, ethnicity, religion, parental 
marital status, family income or household composition 
(Fehon et al., 2001a), consistent with the findings here. 
It is important to note that although there were no 
significant gender differences in the number of PTSD cases 
in the current study, girls reported more severe PTSD 
symptoms than boys. This has also been the finding in 
another adolescent study, using the same PTSD symptom 
severity measure (Child PTSD Checklist) (Fehon et al., 
2001b).  
 
Another interesting observation is that while no 
significant differences were observed in the frequency of 
functional impairment reported by full and partial PTSD 
groups, significant gender differences were seen. Girls 
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were more likely than boys to report current social and 
family (but not school) impairments than boys, suggesting 
that event though rates of PTSD may be similar, girls may 
experience more functional interference than boys.   
 
3.6.6 Comparisons with the school sample 
In comparing these results with that of the school survey 
(Cape Town cohort only), some striking similarities emerge. 
First, in both of these samples the rate of full and 
partial PTSD was comparable in boys and girls. The higher 
number of cases of PTSD (full and partial) in the ‘high-
risk’ treatment-seeking group compared with the ‘low-risk’ 
school sample (47% vs. 22% for full PTSD; 19% vs. 12% for 
partial PTSD) is consistent with expectation.  
 
Second, no significant gender effect was seen with respect 
to the rate of exposure to different trauma types, with the 
exception of sexual assault. In contrast to the school 
sample where no gender difference in the rate of sexual 
assault was observed, more girls than boys reported sexual 
assault in this study. One explanation for this might be 
the different formats used to elicit traumatic events 
(self-report in the school survey, clinician interview 
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here), which could have produced some degree of measurement 
artefact.  
 
Third, multiple trauma exposure (defined as exposure to ≥ 3 
traumas) was common in both samples (55% in this study and 
44% in school cohort), and in line with expectation 
occurred at a higher frequency in the clinic sample. 
Fourth, the two PTSD symptoms that were reported most 
commonly by adolescents (efforts to avoid thoughts, 
feelings, or conversations associated with the trauma and 
efforts to avoid activities, places or people that arouse 
recollections of the trauma) were consistent in the 
studies. Lastly, there were no differences between boys and 
girls in depression severity (as measured on the BDI), and 
the severity of PTSD symptoms (as measured on the Child 
PTSD checklist) correlated positively with the severity of 
depression, in both samples.  
 
One notable difference deserves mention. While in the 
school sample some traumas (sexual assault, physical 
assault by a family member, serious accidents) were 
associated with a significant risk for PTSD, this was not a 
finding here and may be accounted for by a Type II error, 
in view of the comparatively smaller clinic sample. 
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3.6.7 Study limitations and strengths 
Several caveats in this study limit the interpretation of 
results and should be mentioned. First, this was a 
relatively small sample of adolescents. A larger sample 
size would have provided more power for the detection of 
group differences (full PTSD/partial PTSD/no PTSD; 
boys/girls). Second, as the study was cross-sectional in 
design, longitudinal assessment of the disorder (full and 
partial PTSD) in these groups was not possible. Third, 
while data on the number of traumatic events was obtained, 
information on the severity and duration of each traumatic 
event and their relation to PTSD was not. Fourth, there was 
a reliance on patient self-report for some measures of 
violence exposure and psychopathology (viz. PTSD and 
depression symptom severity, community violence, and 
childhood abuse). It has been suggested that the relative 
privacy of the self-report format might produce an 
overreporting of traumatic events and symptoms (Cuffe et 
al., 1998), however, this does not appear to be the case 
here as lower PTSD symptom rates were obtained on the self-
report Child PTSD checklist compared with the clinician-
administered interview. While on the one hand it can also 
be argued that the validity of self-reports in adolescents 
must be viewed with caution as negative mood states and 
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individual response styles in adolescents introduce bias, 
self-report scales may make disclosure of sensitive or 
embarrassing material easier for some youth.  
 
One of the strengths of the study was the emphasis on 
multi-method, multi-score assessments across a variety of 
diagnostic and symptom domains. The sample also comprised 
of adolescents with heterogeneous and compounded trauma 
exposure, comparable to youth populations who present to 
primary care clinics, trauma clinics, and psychiatry 
outpatient settings. Finally, the study groups (PTSD and 
non-PTSD) were ascertained from the same traumatised 
sample, eliminating a variety of selection and sampling 
confounds (du Fort et al., 1993).  
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3.7 Conclusion 
In conclusion, this study is of interest not least because 
it provides descriptive data on violence exposure and its 
considerable impact on the evolution of PTSD and other DSM-
IV disorders in treatment-seeking adolescents. The findings 
indicate that adolescent boys may be just as likely as 
adolescent girls to develop PTSD, irrespective of the kind 
of traumatic event that is experienced, and that once 
developed, there may be little to distinguish full and 
subthreshold syndromes in either gender.  
 
Furthermore, adolescents with partial and full PTSD may 
have comparable rates of interference with respect to 
school, family and social functioning. To date, this 
finding has been documented in only one other youth study, 
comprising a smaller sample (n=59) of children with a mean 
age of 10.6 years (Carrion et al., 2002).  It is, 
therefore, fair to say that this is the first such 
replication in a substantially larger sample of older 
adolescents.  
 
That partial PTSD may be just as disabling, raises 
important clinical issues for professionals working in the 
field of trauma. Detection and provision of appropriate and 
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timely care to adolescents who are exposed to traumatising 
experiences and who meet criteria for partial disorder may 
be just as critical as providing these services to those 
individuals with the full disorder.  
 
Although not yet demonstrated, adolescents who fall short 
of meeting the full criteria set may arguably also benefit 
from pharmacotherapeutic and/ or psychotherapeutic 
intervention. Considering that partial PTSD is a relatively 
common entity in both youth and adult populations, this is 
certainly an area in which further research is needed. 
Treatment of PTSD in adolescents who present to primary 
care and specialised trauma clinic settings needs to be 
sensitive to potential gender-related differences, which 
even if not manifest in differences in prevalence, may well 
manifest in symptom expression, associated morbidity, or 
functional impairment.  
 
The following chapter covers pharmacological intervention 
in a subset of adolescents with full PTSD, who were derived 
from the sample under discussion here.  
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TABLE 1: Demographic Characteristics  
 
 
Demographic Variables 
Total  Sample 
(N=170) 
 
Boys 
 (N=71) 
Girls   
(N=99) 
Age in years (SD)** 13.8    (2.9) 12.6  (2.8) 14.6  (2.8) 
Ethnicity   % (N)           
     White 
     Non-White 
          •Coloured 
          •Black 
 
  
6.5%    (11)  
91.8%   (156) 
78.8%   (134) 
12.9%   (22) 
(missing value: N=3) 
   
  7.4 % (5) 
92.6 % (63) 
 80.3% (57) 
  8.5%  (6) 
 
  6.1 %  (6) 
93.9%  (93) 
77.8%  (77) 
16.2%  (16) 
School Grade  % (N) ** 
 Grade 1 to 6 
 Grade 7 to 12 
 
 
40.6%   (69) 
53.5%   (91) 
(missing value: N=10) 
 
32.9%  (31) 
67.0%  (63) 
 
57.6%  (38) 
42.4%  (28)  
 
Habits (current use)           
 Cigarettes: ≥ 10 per day 
 Alcohol > 3 times per week 
 Cannabis          
   
 8.3%    (14) 
10.6%   (18) 
 4.1%     (7)   
(missing value: N=1) 
  
 10.1% (10)  
 10.1% (10)  
   4.1%  (4)  
 
5.7%    (4) 
11.3%  (8) 
4.2%    (3) 
Parents’ deceased 
       Mother 
       Father 
  
 
10.6%   (18) 
16.5%   (28) 
(missing value: N=2 
for mother and N=4 
for father) 
 
  7.2%    (7) 
16.8%  (16) 
 
15.5%  (11) 
16.9%  (12) 
Parents’ marital status 
Married/living together      
Single/divorced/separated/ 
widowed 
 
 
 42.4%  (72) 
 56.7%  (94)  
 
(missing value: N=4) 
 
40.6%  (39) 
59.4%  (57) 
 
47.1%  (33) 
52.9%  (37) 
Unemployment  
     Mother  
     Father 
 
 
 12.4%  (21) 
   7.1%  (12) 
(missing values: N=33 
for father, and N=19 
for mother) 
 
16.2%  (16) 
10.1%  (10) 
 
 7.0%   (5) 
 2.8%   (2) 
*  denotes significant gender differences at p <0.05 
** denotes significant gender differences at p  <  0.01 
Note: For analysis by gender, percentages are expressed as  
      per gender group  
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TABLE 2: Trauma Type, Age of Occurrence, and Number of Exposures 
 
DSM-IV Traumatic Events 
 
(K-SADS PTSD module) 
 
Age of Occurrence 
in Years 
mean ± SD 
 
Number of 
Exposures 
mean ± SD 
range 
Significant car accident in which 
child/ other individual in car 
was injured and required medical 
intervention  
 
10.8 ± 4.2 
 
 
1.3 ± 0.9 
(0 to 4) 
Other significant accident 
involving injury and requiring 
medical intervention  
 
9.2 ± 3.7 
 
 
0.9 ± 0.4 
(0 to 2) 
Witness to fire that caused 
significant property damage or 
moderate to severe physical 
injuries  
 
9.3 ± 3.6 
 
1.1 ± 0.3 
(1 to 2) 
Witness of a natural disaster 
(e.g., flood, hurricane, other 
natural disaster)  
 
11.5 ± 2.1 
 
1.0 ± 0.7 
(0 to 2) 
 
Witness of a violent crime  
 
11.8 ± 3.5 
 
1.4 ± 1.4 
(0 to 5) 
 
Victim of violent crime 
 
12.3 ± 3.6 
 
1.1 ± 0.9 
(0 to 4) 
 
Confronted with extremely 
traumatic news 
 
11.0 ± 3.6 
 
1.2 ± 0.7 
(0 to 4) 
 
Witness to domestic violence  
 
8.0 ± 3.4 
 
3.2 ± 2.0 
(0 to 10) 
 
Physical abuse  
 
8.6 ± 3.3 
 
2.9 ± 1.9 
(0 to 10) 
Sexual abuse (isolated/ repeated 
incidents of genital fondling, 
oral sex, or vaginal or anal 
intercourse) 
(missing values, N=5) 
 
 
10.7 ± 3.8 
 
 
1.6 ± 1.4 
(0 to 4) 
 
Other very traumatic event 
 
11.8 ± 4.1 
 
1.6 ± 1.1 
(1 to 4) 
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TABLE 3: Trauma Type and PTSD Diagnosis  
 
 
DSM-IV Traumatic Events 
(K-SADS PTSD module) 
 
Total 
(N=170) 
% (count) 
 
Boys 
(N=71) 
% (count) 
 
Girls 
(N=99) 
% 
(count) 
 
p 
Significant car accident  
(missing values, N=6) 
 
11.8%  (20) 
 
17.5%  (12) 
 
 8.3%  (8) 
 
    .09 
Other significant  
(missing values, N=6) 
 
13.5%  (23) 
 
17.5% (12) 
 
11.6% (11) 
 
    .36 
Witness to fire  
(missing values, N=6) 
 
5.3%   (9) 
 
2.9%  (2) 
 
 7.4%  (7) 
 
    .31 
Witness of a natural  
(missing values, N=8) 
 
2.9%   (5) 
 
2.9%  (2) 
 
3.2% (3) 
 
  1.00 
Witness of a violent crime  
(missing values, N=5) 
 
41.2%   (70) 
 
44.1% (30) 
 
41.2% (40) 
 
    .75 
Victim of violent crime 
(missing values, N=5) 
 
25.9%   (44) 33.3% (23) 21.9% (21)     .11 
Confronted with traumatic news 
(missing, N=4) 42.4%   (72) 40.6% (28) 45.4% (44)     .63 
Witness to domestic violence  
(missing, N=6) 48.2%   (82) 50%    (34) 50.0% (48)   1.00 
Physical abuse  
(missing values, N=6) 
 
25.9%   (44) 
 
26.5% (18) 
 
27.1% (26) 
 
  1.00 
Sexual abuse  
(missing values, N=5) 
 
45.9%   (78) 
 
23.5% (16) 
 
63.9% (62) 
 
   .000**
 
Other very traumatic event 20.0%   (34) 25.0% (17) 17.7% (17)     .17 
Mean (SD) number of PTSD 
qualifying events (range: 1 to 7) 
 
2.8 ± 1.5 
 
2.7 ± 1.7 
 
2.9 ±1.4 
 
    .50 
 
Exposure to ≥ 3 traumas 
 
55.3% 
 
50.7% 
 
58.6% 
 
    .19 
PTSD symptom diagnosis (current) 
  Full (missing values: N=18) 
  Partial (missing values: N=18) 
 
47.1% 
19.4% 
 
51.5% 
21.2% 
 
53.5% 
21.8% 
 
    .87 
  1.00 
Mean duration (SD) in weeks of 
PTSD symptoms (irrespective of 
PTSD diagnosis or not) 
 
5.48  (14.6) 
 
3.7  (10.9) 
 
6.6  (16.5) 
 
    .19 
** denotes significant gender differences at p < 0.01  
Note:  Full diagnosis of PTSD based on K-SADS (DSM-IV) criteria. 
Partial PTSD diagnosis based on the presence of 1 re-   
experiencing, 1 avoidance and 1 hyperarousal symptom.  
For the analysis by gender, percentages are expressed as 
per gender group. 
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TABLE 4: Number of Diagnostic Symptoms in Adolescents 
Meeting Full Criteria for PTSD and those not meeting Full 
Criteria 
 
K-SADS Criteria  Full PTSD No PTSD P 
Number of Intrusive 
Symptoms (mean ± SD) 
 
3.3  ± 1.0 
 
1.1   ± 1.1 
 
.000** 
Number of Avoidance 
Symptoms (mean ± SD)  
 
4.6  ± 1.1 
 
1.9  ±  1.6 
 
.000** 
Number of Hyperarousal 
Symptoms (mean ± SD) 
 
4.0  ± 1.0   
 
1.7  ±  1.8 
 
.000** 
**significant gender differences at p < 0.01 
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TABLE 5: Frequency of PTSD Symptoms: Gender Differences 
 
 
Symptom Endorsed on K-SADS 
Total 
(N=170)
% 
Boys 
(N=71) 
% 
Girls 
(N=99) 
% 
P 
Re-experiencing (Cluster B) 
     B1 Intrusive thoughts 
     B2 Nightmares 
     B3 Reliving 
     B4 Psychological distress 
     B5 Physiological reactivity 
 
48.9 
47.3 
37.2 
47.3 
45.7 
 
55.9 
53.7 
50.0 
56.7 
53.0 
 
60.7 
60.2 
43.0 
57.9 
57.9 
 
  .62 
  .51 
  .42 
 1.00 
  .62 
Avoidance cluster (cluster C) 
     C1 Avoids thoughts 
     C2 Avoids people, places 
     C3 Amnestic 
     C4 Diminished interest 
     C5 Detachment/numbing 
     C6 Restricted range of affect 
     C7 Foreshortened future 
 
53.2 
53.2 
39.9 
44.1 
47.3 
48.4 
45.2 
 
58.8 
62.7 
50.0 
50.0 
45.4 
50.0 
54.5 
 
67.4 
63.0 
47.8 
54.9 
54.9 
61.9 
54.4 
 
  .32 
 1.00 
  .87 
.63 
 .02* 
.15 
 1.00 
Hyperarousal cluster (cluster D) 
     D1 Sleep difficulties 
     D2 Irritability 
     D3 Concentration problems 
     D4 Hypervigilance 
     D5 Exaggerated startle 
 
49.5 
46.3 
51.1 
51.1 
52.7 
 
54.5 
44.8 
58.8 
61.8 
56.7 
 
63.3 
63.3 
61.5 
61.5 
67.0 
 
.32 
 .02* 
.75 
.87 
.24 
 
* denotes significant gender differences at p< 0.05 
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TABLE 6: Other Psychiatric Diagnoses: Gender Differences 
 
 
Psychiatric Diagnosis 
and Onset 
Total 
(N=170) 
% (count) 
Boys 
(N=71) 
% (count) 
Girls 
(N=99) 
% (count) 
 
P 
Major Depressive Episode 
             Pre-trauma: N=1 
             Posttrauma: N=33 
 
20.0% (34) 
 
 9.9% (7) 
 
27.3% (27) 
 
.02* 
Acute Stress Disorder  
 (posttrauma onset in all)   
 
19.4% (33) 
 
16.9% (12) 
 
21.2% (21) 
 
.56 
Enuresis 
             Pre-trauma: N=8 
             Posttrauma: N=12 
 
11.8% (20)  
 
12.7% (9) 
 
11.1% (11) 
 
.81 
Specific Phobia 
             Pre-trauma: N=8 
             Posttrauma: N=5 
 
 7.6% (13) 
 
 5.6% (4) 
 
 9.1% (9) 
 
.56 
Oppositional Defiant Disorder 
             Pre-trauma: N=1 
             Posttrauma: N=10 
 
 6.5% (11)  
 
 8.5% (6) 
 
 5.1% (5) 
 
.52 
Attention Deficit Disorder 
             Pre-trauma: N=3 
             Posttrauma: N=5  
 
 4.7% (8) 
 
 8.5% (6) 
 
 2.0% (2) 
 
.07 
Mean no. of diagnoses  
mean ± SD  
range 
 
1.2 ± 1.3 
(0 to 7) 
 
0.9 ± 1.1 
 
1.3 ± 1.3 
 
.05 
*    denotes significant gender differences at p  <0.05 
For the analysis by gender, percentages are expressed as 
per gender group 
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TABLE 7: Mean Scores on Self-Report Measures: Gender 
Comparisons 
 
 
Measure 
Total 
(N =170) 
Boys 
(N=71) 
Girls 
(N=99) 
 
F 
Child PTSD Checklist 
   Intrusive score 
   Avoidance score 
  Hyperarousal score 
  Total score   
 
18.7 ±  8.9 
18.2 ±  8.5 
14.6 ±  7.0 
55.9 ± 26.7 
 
16.5 ± 8.5 
16.5 ± 8.2  
12.9 ± 6.2 
48.5 ± 24.4 
 
20.3 ± 8.9 
19.4 ± 8.6 
15.7 ± 7.4 
60.5 ± 27.2 
 
 0.09* 
 0.17* 
 2.52* 
 0.11**
Beck Depression 
Inventory (BDI) 
 
19.9 ± 14.4 
 
 9.8 ± 11.9  
 
23.3 ± 13.9 
 
 0.8 
Child Exposure to 
Violence Checklist 
(CEVC) Total score 
 
 
29.3 ± 23.2 
 
 
29.3 ± 26.6 
 
 
29.3 ± 20.6 
 
 
 4.9 
Life Events 
Questionnaire for 
Adolescents (LEQ-A) 
 Total number of  
 negative life events 
 
 
 
 8.4 ± 5.8 
 
 
 
 7.3 ± 4.5 
 
 
 
 9.2 ± 6.6 
 
 
 
 4.5* 
Childhood Trauma 
Questionnaire (CTQ) 
   Physical Abuse 
   Sexual Abuse 
   Emotional Abuse 
   Physical Neglect 
   Emotional Neglect  
   Total Score 
 
 
7.0  ± 4.8 
7.4  ± 5.9 
9.5  ± 6.0 
8.3  ± 4.8 
10.5 ± 6.3 
42.7 ± 22.3  
 
 
6.1  ± 3.9 
5.7  ± 4.4 
7.8  ± 4.9 
7.4  ± 4.1 
9.1  ± 5.7 
36.2 ± 18.0 
 
 
 7.6 ± 5.2 
 8.6 ±  6.5 
10.8 ± 6.4 
 8.9 ± 5.1 
11.4 ± 6.5 
47.3 ± 23.9 
 
 
 6.0* 
18.5** 
 7.4** 
 1.3* 
 2.7* 
 4.1** 
 
Gender differences denoted as * p < 0.05, **p < 0.01 
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TABLE 8: Clinical Correlates in Trauma-Exposed Adolescents 
with PTSD, Partial PTSD and No PTSD 
 
 
Measure (Total scores) 
 
Mean 
 
SD 
 
F value 
 
Group 
Differences 
Number of PTSD-qualifying 
traumas 
      Full PTSD 
      Partial PTSD 
      No PTSD   
 
 
  4.6 
  4.2 
  3.8 
 
 
 4.2 
 3.7 
 2.9 
 
 
 
  0.4 
 
 
 
ns 
Child Exposure to Violence 
Checklist (CEVC)  
      Full PTSD 
      Partial PTSD 
      No PTSD   
 
 
 
 30.4 
 22.8 
 31.1 
 
 
 
22.9 
21.7 
26.0 
 
 
 
 
  1.1 
 
 
 
ns 
Negative Life Events (LEQ-
A) 
      Full PTSD 
      Partial PTSD 
      No PTSD 
 
 
  8.3 
  8.1 
  9.3 
 
 
 4.9 
 6.2 
 7.2 
 
 
 
  0.5 
 
 
ns 
Childhood Trauma 
Questionnaire (CTQ) 
      Full PTSD 
      Partial PTSD 
      No PTSD 
 
 
 42.2 
 39.5 
 44.8  
 
 
20.7 
25.1 
18.2 
 
 
 
  0.6 
 
 
 
ns 
Analysis of variance (ANOVA) using Tukey post hoc tests. 
Groups: Full PTSD (n=80), Partial PTSD (n=33), and No PTSD 
(n= 39), missing: n=18  
ns=Group differences were not significant 
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4. PHARMACOTHERAPY OF ADOLESCENT POSTTRAUMATIC STRESS 
DISORDER  
 
 
Pilot Study of Treatment with the Selective Serotonin 
Reuptake Inhibitor, Citalopram, in Adolescents with 
Posttraumatic Stress Disorder (PTSD) 
 
4.1 Study Summary 
In this preliminary 12-week open-label study, eight 
adolescents with moderate to severe PTSD were treated with 
citalopram (the most selective of the SSRIs) in a fixed 
daily dose of 20mg, and rated at 2-week intervals. The 
Clinician-Administered PTSD Scale (Child and Adolescent 
Version) was the primary variable used to assess treatment 
outcome. 
 
Core PTSD symptoms (re-experiencing, avoidance, and 
hyperarousal symptoms) showed statistically significant 
improvement at week 12 on the Clinician-Administered PTSD 
Scale (Child and Adolescent Version) (CAPS), with a 38% 
reduction in total CAPS scores between baseline and 
endpoint.  Citalopram failed to effect improvement on self-
reported depressive symptoms. All 7 adolescent completers 
were rated as much improved or very much improved on 
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Clinical Global Impression-Improvement scores. Citalopram 
was well-tolerated overall with reported adverse 
experiences being relatively benign.  
 
The differential improvement on PTSD symptom clusters but 
not on depression suggests that citalopram might be a 
promising treatment for PTSD in adolescents, independent of 
its antidepressant effects.  
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4.2 Introduction 
As has been highlighted in previous chapters, PTSD is a 
prevalent, and often disabling consequence of trauma 
exposure in children and adolescents (Berman et al., 1996; 
Breslau et al., 1991). Empirical data, gleaned primarily 
from adult populations, reinforces the specific 
neurobiological basis of PTSD, its diagnostic validity, and 
responsiveness to both pharmacotherapeutic and 
psychotherapeutic strategies (van der Kolk, 1997). More 
recently, the role of serotonin in underlying the 
pathophysiology of PTSD has been highlighted by a wealth of 
preclinical and clinical data (Connor and Davidson, 1998). 
Results of animal and clinical studies (paroxetine binding, 
pharmacologic challenge tests, and neuroimaging techniques) 
suggest that serotonergic agents, specifically, selective 
serotonin reuptake inhibitors (SSRIs) might be beneficial 
in ameliorating PTSD symptoms (Connor and Davidson, 1998), 
and several authors have postulated that SSRIs may exert 
their effects indirectly rather than directly, through 
modulation of non-serotonergic neurobiologic systems 
(Friedman, 1998; Friedman, 2000; Donnelly et al., 1999). 
 
In adults, the safety and efficacy of SSRIs in treating 
both core and secondary PTSD symptoms has been borne out by 
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several open and randomised controlled trials (Davidson et 
al., 1998; Marshall et al., 1998; Meek and Kablinger, 1998; 
Brady et al., 1995; Fichtner et al., 1997).  For example, 
in a seminal study leading to the SSRI, sertraline’s 
indication for the treatment of adult PTSD, Brady et al. 
(2000) demonstrated effectiveness over placebo in 94 
patients treated with sertraline (versus 93 with placebo) 
on 3 of 4 primary outcome measures. While the SSRIs may act 
in a fairly rapid, broad spectrum fashion in PTSD, optimal 
results may entail relatively high doses for 8 to 12 weeks 
(Donnelly and Amaya-Jackson, 2002). 
 
In children with PTSD, the few pharmacological studies have 
reported benefits from clonidine patches (n=7 children) 
(Harmon and Riggs, 1996), propranolol (n=11 children) 
(Famularo et al., 1988), carbamazepine (n=28 children) 
(Looff et al., 1995), and guanfacine (n=1 child) (Horrigan, 
1996). None of these studies utilised a control group. In 
addition, anecdotal evidence exists for using 
antidepressants (tricyclics and SSRIs) in children with 
PTSD characterised by prominent depressive or panic 
symptoms (Brent et al., 1995). 
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The efficacy of the SSRIs in paediatric depression and 
anxiety has only recently been supported by controlled data 
(Emslie et al., 1997; Jensen et al., 1999; Pine, 2001). 
With their “broad spectrum” of activity, the SSRIs are 
receiving more diverse application in child and adolescent 
disorders, including depression, obsessive-compulsive 
disorder, social anxiety disorder, and selective mutism, 
and fluoxetine, sertraline and fluvoxamine are both FDA-
approved for use in paediatric OCD.  (Black and Uhde, 1994; 
Allen et al., 1995; Kutcher 1997; Beidel et al., 1999; 
Emslie et al., 1999; Murphy et al., 2000; Kastelic et al., 
2000; Ziervogel, 2000). 
 
Despite the lack of open and controlled trials in children 
and adolescents with PTSD, SSRIs have been recommended as 
first-line agents in clinical practice (Cohen et al., 
1998). However, some authors recommend that their use in 
child and adolescent PTSD be reserved for comorbid or 
disabling symptoms (Marmar et al., 1994). Considering their 
favourable side-effect profile and broad therapeutic index, 
SSRIs offer specific advantages over tricyclic 
antidepressants in paediatric populations (Leonard et al., 
1997). In childhood PTSD, the SSRIs may have two distinct 
roles: first, in targeting disabling symptoms to allow for 
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a normal growth and developmental trajectory and second, to 
facilitate confrontation with emotionally traumatic 
material in psychotherapy and in day-to-day life (Donnelly 
et al., 1999). 
 
This preliminary study undertook to treat a sample of 
adolescents presenting with PTSD with the highly selective 
SSRI, citalopram. Citalopram is a bicyclic phthalane 
derivative, with no effect on the uptake of noradrenaline, 
dopamine, or GABA. Moreover, neither citalopram nor its 
metabolites have significant antidopaminergic, 
antiadrenergic, antiserotonergic, antihistaminergic, or 
anticholinergic properties (Milne and Goa, 1991). With 
respect to citalopram, both controlled studies in adult 
mood and anxiety disorders (Tan and Levin, 1999; Wade et 
al., 1997; Lepola et al., 1998; Birmaher et al., 2003) and 
open-label studies in child and adolescent OCD (Thomsen, 
1997; Mukaddes et al., 2003) suggest favourable efficacy 
and tolerability. In a recent placebo-controlled study of 
citalopram (20mg to 40mg/day) for paediatric patients (12-
17 years) with major depression, mean child-Depression 
Rating Scale-Revised scores decreased significantly more 
from baseline in the citalopram treatment group than in the 
placebo treatment group, with differences already evident 
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in the first week (Wagner et al., 2004). Citalopram has 
also demonstrated short-term efficacy and safety as a 
treatment for impulsive aggression in children and 
adolescents (aged 7 to 15 years) (Armenteros and Lewis, 
2002) and in preliminary data from children and adolescents 
with autism treated with citalopram, it was suggested that 
this agent was useful in the reduction of symptom domains 
such as repetitive behaviours and anxiety and mood symptoms 
(Namerow et al., 2003). Finally, in a retrospective chart 
review of child and adolescent outpatients treated with 
citalopram for depressive or anxiety disorders and a high 
degree of comorbidity, citalopram appeared to be effective 
and well-tolerated (Baumgartner et al., 2002). 
 
This trial investigated (i) the preliminary efficacy of 
citalopram in treating PTSD symptoms in adolescents and 
(ii) the tolerability of this agent in this age group.  
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4.3 Methods 
Adolescents aged 12-18 years meeting DSM-IV criteria for 
PTSD, as determined by the CAPS-CA (Clinician Administered 
Posttraumatic Stress Disorder Scale-Child and Adolescent 
version) (Nader et al., 1996) were entered into a treatment 
protocol approved by the ethics committee of the University 
of Stellenbosch Medical School, Cape Town. Adolescents were 
recruited from the Bathuthuzele Clinic, an outpatient unit 
for children and adolescents exposed to traumatic 
experiences. Written informed consent for study inclusion 
was obtained from a parent or legal guardian. A criterion 
for entry into the study was a Clinical Global Impression 
(CGI) severity score of ≥ 4 (at least moderate severity 
PTSD) (Guy, 1976).  
 
The presence of comorbid mood and anxiety disorders was not 
an exclusion criterion, provided these disorders did not 
precede the PTSD diagnosis. Comorbidity was screened for 
with the K-SADS (Schedule for Affective Disorders and 
Schizophrenia for School-Age Children-Present and Lifetime 
Version) (Kaufman et al., 1997). K-SADS interviews were 
conducted by a clinical psychologist. 
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Adolescents who had been treated with SSRIs at therapeutic 
antidepressant doses for at least 4 weeks prior to study 
entry were excluded, as were adolescents meeting DSM-IV 
criteria for psychotic, bipolar, or organic disorders. 
Adolescents with a substance abuse/dependency diagnosis in 
the preceding 6 months, or an unstable medical condition, 
were also excluded. Prior to study entry, adolescents were 
kept medication-free for at least 2 weeks. Concomitant 
psychotropic medications and formal psychotherapies 
(excluding supportive psychotherapy) were contraindicated 
for the duration of the trial.  
 
The primary outcome variable was a mean change from 
baseline in PTSD symptoms, as assessed by the CAPS-CA. All 
CAPS-CA interviews were performed by the treating 
psychiatrist. The CAPS-CA was used both as a reference 
standard to establish PTSD caseness and treatment outcome. 
Modelled after the adult CAPS (Blake et al., 1990), the 
CAPS-CA provides scalar and categorical assessment of PTSD 
and PTSD-related psychopathology, such as hostility and 
school problems (Nader et al., 1996). The CAPS-CA measures 
17 PTSD symptoms based on DSM-IV criteria. Symptoms are 
grouped into categories of: (1) re-experiencing symptoms 
(items 1-5, maximum score 40), (2) avoidance/numbing 
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symptoms (items 6-12, maximum score 56), and (3) 
hyperarousal symptoms (items 13-17, maximum score 40). The 
CAPS-CA is useful in children aged 8 through to 
adolescence. Besides establishing a current and/or lifetime 
diagnosis of PTSD; the scale measures overall severity of 
PTSD symptoms, frequency and severity of each symptom, and 
impact of symptoms on developmental, social, and scholastic 
functioning.     
 
Secondary outcome measures of depression, and PTSD symptom 
severity and improvement, were assessed using the Zung 
Depression Self-Rating Scale, and Clinical Global 
Impression-Severity and Improvement Scales (CGI-S and CGI-
I) (Guy, 1976). CGI-Improvement scores at endpoint 
distinguished responders from non-responders. A final CGI-I 
score of 1 or 2 (much or very much improved) defined 
"response", while a final CGI-I score of ≥ 3 (minimally 
improved or worse) defined "non-response". Adolescents were 
assessed at 2 weekly intervals over 12 weeks of open 
treatment with citalopram. Citalopram was initiated at 
20mg, and this dose was fixed throughout the 12 week 
period. At every visit, the CAPS-CA (clinician-rated), Zung 
Depression Scale (patient-rated), and CGI (clinician-
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rated), were administered. Adverse events were documented 
at visits.  
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4.4 Results 
4.4.1 Sample  
Eight adolescents entered the study, and seven completed 12 
weeks of treatment. One subject was withdrawn at 2 weeks 
due to adverse events (nose bleeds). The mean age of 
subjects was 14.8 years (SD=2.7), with a mean level of 
schooling of 8.75 years (SD=2.4). There were 7 girls and 1 
boy, their racial composition being: mixed race (4), Black 
(2), White (1), and Asian (1). The majority presented with 
chronic PTSD, with mean duration of PTSD symptoms 16.5 
months (SD=16.4, range 2 to 48 months, median 14 months). 
Only 2 of the 8 adolescents met criteria for "acute 
PTSD"(duration of symptoms < 3 months). Four adolescents had 
a "delayed onset" (symptoms ≥ 6 months after the traumatic 
event).  
 
Traumatic events reported included: rape (3), childhood 
sexual abuse (3), physical abuse (2), physical injury from 
a gunshot (1), witnessing sudden death of a friend (1), and 
witnessing domestic violence (1) (Table 1). Six had 
directly experienced trauma, while two had been witnesses 
to trauma. Five of the eight had been victims of multiple 
traumas leading to the development of PTSD. 6 of the 8 met 
criteria for current major depressive episodes (which were 
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mild in severity), while none met criteria for a past 
(lifetime) diagnosis. 1 adolescent had comorbid panic 
disorder (current) and separation anxiety disorder (past).     
 
4.4.2 Outcome 
All 7 subjects were responders to citalopram on the CGI-
Improvement Scale at endpoint (week 12), with 3 completers 
much improved (CGI-I=2), and 4 very much improved (CGI-
I=1). 
 
Paired t-tests (n= 7 completers) demonstrated significant 
differences between baseline and endpoint CAPS scores for 
all three symptom clusters (Table 2). There was a mean 
reduction of 50 points (38%) in total CAPS scores between 
baseline and endpoint (Table 3 and Figure 1). There was 
also a significant difference between baseline and endpoint 
CGI severity scores (t=6.97, p=0.0004). There was no 
significant difference between baseline and endpoint Zung 
depression scores. 
 
Citalopram (20mg) was well tolerated, and reported adverse 
effects were mild and self-remitting. Common adverse 
effects experienced were increased sweating (n=3), nausea 
(n=2), headache (n=2), and tiredness (n=2). 1 adolescent 
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experienced akathisia (of moderate severity), which 
resolved without any intervention, 3 weeks into the trial.  
The only adolescent who did not complete the trial was 
withdrawn at 2 weeks (at the request of his parents) after 
3 episodes of nose bleeding (epistaxis) on day 10.  He had 
1 further episode two weeks after citalopram 
discontinuation. All 4 nose bleeds were mild, and did not 
require medical intervention. Physical examination at the 
time revealed no abnormalities. In retrospect, the nose- 
bleeds did not appear to be related to the study drug.  
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4.5 Discussion 
These findings suggest that citalopram may be an effective 
agent in adolescents with PTSD, as demonstrated by a 38% 
mean symptom reduction score between baseline and endpoint, 
as well as significant reduction in all 3 PTSD symptom 
cluster scores (intrusive, avoidance, hyperarousal) over 12 
weeks. Both the magnitude of symptom reduction and the 
time-to-improvement, are in line with open trials of SSRIs 
in adults (van der Kolk et al., 1994; Hertzberg et al., 
1998). Despite the low placebo response in a number of 
controlled trials of adult PTSD (5-10%); placebo response 
rate has tended to be higher in non-veteran samples. The 
small sample size of this trial, and absent placebo arm, 
are limiting factors. Findings of this study will need to 
be confirmed in larger-sample, controlled trials.  
 
Six adolescents satisfied criteria for comorbid depression 
(MDD) at study entry. Interestingly, while 5 of the 6 no 
longer met criteria for MDD at study end; depressive 
symptoms as measured by the self-report Zung Scale (paired 
t-tests of means) did not improve. These differences might 
reflect depression severity at baseline (mild severity, low 
Zung scores). Co-morbidity between PTSD and depression has 
been well documented in the literature (Goenjian et al., 
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1995; Hubbard et al, 1995), and it has been hypothesized 
that PTSD might precede and predispose to the onset of 
depression (Goenjian et al., 1995). 
 
Citalopram was well tolerated overall. This is consistent 
with studies of citalopram in child and adolescent 
obsessive-compulsive disorder (Thomsen and Mikkelsen, 1995; 
Thomsen, 1997). 
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4.6 Conclusion 
This preliminary open trial of citalopram in eight 
adolescents is the first published trial of SSRI use in 
adolescent PTSD. Interestingly, the findings suggest that 
the beneficial effects of citalopram on PTSD symptoms might 
not necessarily be a function of its antidepressant 
effects.  
 
Given the approved safety and tolerability of the SSRIs, 
and given the morbidity associated with PTSD, the findings 
of this study hold promise for the treatment of this 
disorder in this population.   
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TABLE 1: Trauma and PTSD Characteristics (N=8) 
 
Patient Trauma Type 
 
Acute 
 
<3months
 
Chronic 
 
≥3months
 
Delayed 
 
≥6months 
Duration 
of PTSD 
Symptoms 
(months) 
1 Rape No Yes No 4 
2 Repeated sexual abuse Yes No Yes 2 
3 Witnessing domestic violence No Yes Yes    24 
4 
Repeated physical 
and sexual 
abuse/rape 
No Yes No    24 
5 
Repeated 
physical/ 
Sexual abuse/ 
2 rapes 
No Yes No    24 
6 
Shooting/ 
Gunshot wound/ 
Loss of baby 
No Yes No 4 
7 Witnessing death of friend Yes Yes Yes 2 
8 
Witnessing mass 
genocide in 
Rwanda 
No Yes Yes    48 
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TABLE 2: Mean Total Scores (SD): CAPS-CA, ZUNG, CGI-S 
                   (N=7 Completers) 
 
      Baseline 6 Weeks 12 Weeks 
CAPS-CA 81   (14.9)   39.9 (20.4) 31   (17.2) 
ZUNG 41.5 (4.9)   41.3 (7.3) 41.2 (6.1) 
CGI-S  5.1 (0.7) 3.6 (0.8)  2.6 (0.8) 
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TABLE 3: CAPS-CA Symptom Cluster Scores (sum of frequency 
and severity scores, paired two sample t-tests for means 
[N=7])  
 
 Mean Score p value 
 Baseline 12 weeks  
Re-experiencing 27.0 (5.5)  8.1 (7.8) 0.001 
Avoidance 27.7 (7.8) 11.8 (8.1)  0.0001 
Hyperarousal 26.3 (6.9) 11.6 (5.8) 0.001 
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FIG. I: Mean CAPS-CA Scores versus Time Course in Weeks  
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Significant reduction in mean CAPS-CA total scores between 
week 0 and week 4   (p<0.0002) 
Significant reduction in mean CAPS-CA total scores between 
week 4 and week 12 (p<0.01)   
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5. PHARMACOTHERAPY OF ADOLESCENT POSTTRAUMATIC STRESS 
DISORDER  
 
 
Comparison of Response to Citalopram in Adolescents and 
Adults with Posttraumatic Stress Disorder 
 
 
5.1 Study Summary 
As has been highlighted, the SSRIs may play a role in 
treating the essential symptoms of posttraumatic stress 
disorder (re-experiencing, avoidance, numbing, 
hyperarousal) in both children and adolescents. As a 
follow-up to the pilot study described, this trial compared 
outcome in adolescents and adults with a DSM-IV diagnosis 
of PTSD.  
 
Twenty-four children/adolescents and 14 adults assessed for 
PTSD severity at baseline were followed up on citalopram 
treatment (20-40mg/day) at 2-weekly intervals over 8 weeks. 
The Clinician-Administered PTSD Scale (CAPS) and the 
Clinical Global Improvement Scale (CGI) were used as 
outcome measures. 
 
There were no significant differences in outcome measures 
between adolescents (n= 24) and adults (n=14), and both 
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groups had significant reductions in mean CAPS total 
scores, symptom cluster scores, and CGI ratings, at 
endpoint.   
 
While the SSRIs have established efficacy and safety in the 
treatment of adult PTSD, literature on their use in child 
and adolescent PTSD is sparse. Controlled data is needed to 
support the clinical perception that SSRIs are agents of 
choice in the treatment of paediatric posttraumatic stress 
disorder. In the interim, these data do suggest continuity 
in treatment response across adult and adolescent PTSD 
populations.  
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5.2 Introduction 
As the previous study demonstrated, appropriate 
pharmacological management of PTSD with SSRIs (also 
incorporating aspects of education and psychosocial 
support) may be potentially useful in adolescents in 
reducing core symptoms (e.g., flashbacks, nightmares, 
avoidance of reminders of the trauma, restricted range of 
emotions, and hyperarousal symptoms) (APA, 1994) and 
improving overall well-being and functioning (Davidson, 
2000).  
 
This study, a follow-up to the preliminary open-label study 
(Chapter 4), examined between-group differences in response 
to citalopram in adolescents and adults with DSM-IV 
posttraumatic stress disorder (APA, 1994). (Seedat et al., 
2000; Seedat et al., 2001). It provides data on a larger 
sample of adolescents (three-fold the size of the original 
sample) as well as a comparative analysis of response to an 
SSRI in adolescent and adult PTSD.  
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5.3 Methods 
24 adolescents (aged 10 to 18 years) and 14 adults (aged 19 
years upwards) with a current PTSD diagnosis (DSM-IV) 
(American Psychiatric Association, 1994) of at least 
moderate severity (as determined by a Clinical Global 
Impression Severity score of ≥ 4) (CGI-S) (Guy, 1976), were 
eligible for trial inclusion. Diagnostic specificity was 
ascertained by means of the Structured Clinical Interview 
for DSM-IV (SCID-1) (First et al., 1995) and the Clinician-
Administered PTSD Scale-Diagnostic and Symptom Status 
versions (CAPS) (Blake et al., 1990; Blake et al., 1995) in 
adults; the Kiddie-Schedule for Affective Disorders and 
Schizophrenia for School-Age Children-Present and Lifetime 
Version (K-SADS) (Kaufman et al., 1997) and the Clinician 
Administered Posttraumatic Stress Disorder Scale-Child and 
Adolescent version (CAPS-CA) (Nader et al., 1996) in 
adolescents. The SCID-I (adults) and K-SADS (adolescents) 
also captured the onset and duration of PTSD symptoms. The 
presence of comorbidity was screened for using the SCID-1 
(adults) and K-SADS (adolescents) (First et al., 1995; 
Kaufman et al., 1997).  
 
The study was approved by the ethics committee of the 
University of Stellenbosch Medical School, Tygerberg. 
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Written informed consent for trial inclusion was obtained 
from all adult participants, and from the parents or legal 
guardians of adolescents (in addition, adolescents gave 
assent). Subjects were recruited via media advertisement 
between 1997 and 2000. 
 
Subjects who met DSM-IV criteria for a psychotic disorder, 
bipolar disorder, organic disorder, and/or substance 
abuse/dependency in the preceding 6 months, were excluded. 
The presence of comorbid mood and anxiety disorders were 
not exclusions, provided that these disorders did not 
precede the primary PTSD diagnosis. Additionally, subjects 
who had previously been on citalopram treatment were 
excluded. There was a 2-week washout period for all 
subjects on benzodiazepines and/ or antidepressants (except 
for fluoxetine: 5-week washout). Concomitant 
pharmacotherapy or psychotherapy was not permitted during 
the trial, however, supportive counselling was provided by 
the treating clinician. 
 
The primary outcome measures were: (1) mean change from 
baseline in PTSD symptoms as assessed by the CAPS (adults) 
(Blake et al., 1990; Blake et al., 1995) and CAPS-CA 
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(adolescents) (Nader et al., 1996) and (2) Clinical Global 
Impression (CGI) (Guy, 1976) change scores at endpoint.  
 
CAPS (adults) and CAPS-CA (adolescents) interviews were 
used to establish both PTSD caseness and treatment outcome. 
Based on the adult CAPS, the CAPS-CA (used in children aged 
8 upwards) measures the seventeen core PTSD symptoms (DSM-
IV) grouped in categories of: (1) re-experiencing (items 1-
5, maximum score 40), (2) avoidance/numbing (items 6-12, 
maximum score 56), and (3) hyperarousal (items 13-17, 
maximum score 40). CAPS and CAPS-CA interviews were 
administered by the treating clinician at 2 weekly 
intervals over 8 weeks.  
 
CGI-improvement scores at endpoint distinguished responders 
from non-responders. A final CGI-I score of 1 or 2 (much or 
very much improved) defined "response", while a final CGI-I 
score of ≥ 3 (minimally improved or worse) defined "non-
response". Citalopram was initiated at 20mg/daily, and up-
titrated after 2 weeks to a maximum daily dose of 40mg, if 
tolerated. Adverse events were documented at all clinic 
visits.  
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5.4 Results 
A comparison of the two groups with respect to demographic 
features, index trauma, multiplicity of trauma, and 
onset/duration of PTSD symptoms, is presented in Table 1. 
 
5.4.1 Demographic characteristics 
Seventeen adolescents (71%) entered completed 8 weeks of 
treatment. The sample comprised 16 girls and 8 boys. The 
adult group (n = 14) comprised 7 men and 7 women, with 11 
completers (79%) by week 8.  The sample as a whole 
comprised 8 "Caucasian" subjects, 5 "Black" subjects, and 
25 subjects of "mixed" race. The mean age of adolescent 
subjects was 14.3 years ± 2.3 (range 10 to 18 years, median 
14 years) while the mean age of adult subjects was 33.5 
years ± 8.4 (range 20 to 52 years, median 33.5 years). 
 
5.4.2 Trauma type 
In the adolescent group, traumatic exposure included 
rape/other sexual assault (n = 14), witnessing of violence 
or death (n = 8), perpetration of violence (n = 1) [16 
year-old boy who accidentally stabbed his 18 year-old 
brother to death in an argument], and violent physical 
assault (n = 1). Adult traumas constituted rape/other 
sexual assault (n=5), violent physical assault (n=5), 
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combat (n = 2), torture (n=1), and witness to extreme 
violence/physical harm (n=1).   
 
5.4.3 PTSD symptoms 
The mean duration of PTSD symptoms prior to treatment for 
adolescents was 10.96 months (± 10.95) (range: 2 to 48 
months, median: 6 months), while the mean duration of PTSD 
symptoms for adults was 38.4 months (± 50.8) (range 3 months 
to 141 months, median 13 months).  Only 6 of the 24 
adolescents (25%) met criteria for acute PTSD (duration of 
PTSD symptoms < 3 months). In addition, 6 adolescents had a 
delayed onset of symptoms (≥ 6 months after the traumatic 
event). In the adult group, only 1 of 14 adults met 
criteria for ‘acute PTSD’.  Four had ‘delayed onset’ of 
symptoms.  
 
On baseline assessment of symptom severity (Clinical Global 
Severity score) (CGS) (Guy, 1976), 6 adolescents (25%) vs. 
8 adults (57%) were classified ‘moderately ill’ (CGS = 4), 
while 18 adolescents (75%) vs. 6 adults (43%) were 
classified ‘markedly ill’ (CGS = 5). Differences in 
baseline CGS scores did not reach statistical significance 
for the groups (χ2 test).    
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5.4.4 Comorbidity 
Half of all adolescents (n=12) met criteria for a current 
diagnosis of major depressive disorder (MDD) (mild/ 
moderate severity). In the adult group, 6 (36%) met 
criteria for either current major depressive disorder or 
dysthymic disorder, of post-traumatic onset. There was no 
statistically significant difference between adolescents 
and adults in comorbidity with depression (χ2). 
Additionally, 1 adolescent met criteria for panic disorder 
(current diagnosis) and separation anxiety disorder 
(lifetime diagnosis). Lifetime diagnoses among adults 
included alcohol abuse and dependence (n=2), bulimia 
nervosa (n=1), attention deficit/hyperactivity disorder 
(n=1), and eating disorder not otherwise specified (n=1).  
 
5.4.5 Early withdrawal 
The mean daily dose of citalopram was 27.9 mg (± 9.95) in 
the adult group and 20.0 mg (± 3.53) in the adolescent 
group.  Medication compliance was high in both groups. In 
the adolescent group, 5 subjects were lost to follow-up and 
2 were withdrawn due to adverse events (withdrawal at 2 
weeks due to nose bleeds, withdrawal at 4 weeks due to skin 
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rash). In the adult group, 3 subjects were lost to follow-
up while none were withdrawn on account of adverse events. 
 
5.4.6 Reported adverse events 
Citalopram (20mg) was well tolerated overall. Most reported 
adverse events were mild and self-remitting. Amongst 
adolescents, treatment-emergent effects included drowsiness 
(n =10), headache (n = 7), nausea (n = 7), and increased 
sweating (n=5), while yawning, insomnia, dizziness, tremor, 
and increased appetite, were less commonly reported. One 
adolescent experienced akathisia (of moderate severity) 
which resolved without any intervention at three weeks. Two 
adolescents were withdrawn due to adverse events. One 
developed a skin rash in the first week of commencing 
citalopram, which resolved within 10 days of 
discontinuation. The other was withdrawn at 2 weeks (at the 
request of his parents) following three nosebleeds on day 
10, and another episode two weeks after medication 
discontinuation. These nosebleeds were mild, did not 
require medical intervention, and in retrospect may not 
have been study drug-related.  
 
Adult subjects most commonly reported drowsiness (n=5), 
nausea (n=4), headaches (n=2), dry mouth (n=2), and 
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diarrhoea (n=2). Less commonly reported events included 
increased sweating, blurred vision, and constipation. No 
episodes of self-harm of suicidal were reported. 
 
5.4.7 Prior treatment for PTSD 
Amongst adolescents, previous treatments included tricyclic 
antidepressant medication (amitriptyline and imipramine x 1 
month) (n=2) and supportive therapy (n = 7). Previous 
treatments in adults included SSRIs (sertraline and 
fluoxetine x 6 months) (n = 2) and tricyclic 
antidepressants (amitriptyline x 3 months) (n= 2). 
 
5.4.8 Response characteristics 
Of the 17 adolescent completers, 16 (94%) were ‘responders’ 
on CGI-improvement scores at endpoint (week 8): 5 
completers were ‘much improved’ (CGI=2) and 9 completers 
were ‘very much improved’ (CGI=1). Of the 3 ‘non-
responders’, one was ‘minimally improved’ at endpoint, 
while two were ‘minimally worse’ (CGI= 5). Of the 11 adult 
completers, 9 adults (82%) were classed as ‘responders’: 6 
completers were ‘much improved’ (CGI= 2) and 3 completers 
were ‘very much improved’ (CGI= 1). The two ‘non-
responders’ were ‘minimally improved’ (CGI = 3) at 
endpoint. There were no significant differences in either 
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group between CGI responder status and (i) 
immediate/delayed onset PTSD (χ2 test), (ii) single/multiple 
trauma, (χ2 test), (iii) duration of symptoms (Mann-Whitney 
U test), and (iv) gender (χ2 test). There was also no 
significant association between CGI responder status and 
comorbid depression for either group (Fisher’s exact test). 
Furthermore, in both groups, there were no significant 
differences between completers and non-completers in CGI 
responder status and the abovementioned variables: gender, 
PTSD onset, PTSD duration, and comorbidity with depression.  
 
For individual groups, paired t-tests demonstrated 
significant differences between baseline and endpoint CAPS 
total scores, baseline and endpoint CGI-severity scores, 
and baseline and endpoint symptom cluster scores (re-
experiencing, avoidance/ numbing, and hyperarousal), for 
completers (Table 2). In the intent-to-treat analysis with 
the last observation carried forward (LOCF), the difference 
between baseline and endpoint (week 8) CAPS re-experiencing 
scores and baseline and endpoint CGI-severity scores was 
not statistically significant.   
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In the adolescent group (n=24), there was a mean reduction 
of 42.9 points (54 %) in CAPS total scores between baseline 
and endpoint (t= 9.88, p < 0.001). In the adult group 
(n=14), there was a mean reduction of 30.9 points (39 %) in 
CAPS total scores between baseline and endpoint (t = 6.4, p 
< 0.001). There were no significant differences in CAPS 
total scores (student t-test) and CGI responder status (CGI 
cut-off score of 1 or 2 defined ‘response’) between the two 
groups at any of the time points (week 0, 2, 4, 6, and 8) 
(Fig. 1) (χ2 tests). However, the difference between the 
groups in improvement on hyperarousal cluster symptoms was 
significant (t=3.87, p <.001), with adolescents 
demonstrating greater improvement at week 8.  
 
Efficacy analyses (CAPS total score and CGI severity score) 
using a general linear models (GLM) analysis of variance 
with group as a main effect and time as a repeated measure 
did not reveal significant time effects or group x time 
interactions. 
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5.5 Discussion 
Although there were no significant differences in overall 
treatment response or time-to-response between the groups, 
both adolescents and adults had significant reductions in 
mean CAPS total scores and CGI scores at endpoint (week 8), 
with adolescents demonstrating greater reduction in mean 
CAPS total scores. With respect to PTSD symptom clusters, 
adolescents had significantly greater improvement in 
hyperarousal symptoms, but not re-experiencing and 
avoidance symptoms, compared with adults at week 8 (Table 
2). Duration of PTSD symptoms and mode of onset of PTSD 
(immediate vs. delayed) did not impact on treatment outcome 
for either group. There are few studies that have examined 
the relationship between the delayed-onset subtype of PTSD 
and treatment-response (Hermann and Eryavec, 1994; Solomon 
et al., 1995; Buckley et al., 1996; Ehlers et al., 1998).  
 
The high prevalence of co-occurring MDD and dysthymia in 
our sample (36% of adults, 50% of adolescents) is supported 
across several studies that suggest that PTSD and MDD in 
trauma victims may be influenced by overlapping or common 
vulnerabilities (Kessler et al., 1995; Breslau et al., 
2000). While in this study the presence of comorbid 
depression did not significantly affect treatment outcome 
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in either group, it is widely known that comorbidity 
negatively impacts on prognosis and course of illness. 
There has been little investigation of the treatment of 
comorbid PTSD and MDD or dysthymia; however, many of the 
agents that have demonstrated efficacy in the treatment of 
PTSD are also antidepressant agents (Brady et al., 2000).   
 
These findings suggest similar effects for citalopram on 
core PTSD symptoms in both adolescent and adult subjects.  
Given the many other differences (demographic 
characteristics, duration of PTSD symptoms) between the 
groups, the similarity in treatment response may be 
indicative of ‘continuity’ in the underlying neurobiology 
of the disorder in different cohorts. Both groups were 
treated with a comparable mean daily dose of citalopram, 
consistent with SSRI dosing schedules employed across 
paediatric and adult anxiety disorders. The reasons for 
response to similar dosing schedules across this age 
spectrum might be two-fold: (i) although developmental 
differences in children and adolescents are known to impact 
on the pharmacokinetics of SSRIs, these differences become 
less marked around puberty and, (ii) serotonergic 
neurotransmission and serum concentrations of serotonin 
metabolites do not alter significantly with childhood 
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development which could account for lack of significant 
pharmacodynamic differences (Vitiello and Jensen, 1995; 
Tosyali and Greenhill, 1998; Murphy et al., 2000).  
 
Tolerability of citalopram was also similar for the groups, 
and commonly occurring adverse effects (gastrointestinal, 
central nervous system) were generally mild and short-
lived. Behavioural activation (motor restlessness) was seen 
in one child, but did not result in medication 
discontinuation.  The emergence of epistaxis in another 
child did result in medication discontinuation. While SSRI-
associated haemostatic dysfunction (mechanism: reduction of 
serotonin leading to disturbances in platelet function) 
appears to be a rare adverse effect (Berk and Jacobson, 
1998), bruising and epistaxis have been described in 
children 1 week to 3 months after starting SSRI treatment 
(Lake et al., 2000). Overall, adverse effects in 
adolescents in this study were consistent with those 
reported in other paediatric SSRI studies. 
 
The findings are encouraging, however, interpretation is 
limited by a small sample size, absence of placebo-
controlled/ double-blind design, and lack of assessment 
measures beyond core PTSD symptoms (i.e., no measures of 
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depression, disability).  Another shortcoming was the lack 
of an independent evaluator to administer outcome measures.  
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5.6 Conclusion 
In conclusion, while evidence for efficacy of the SSRIs in 
adult PTSD is fairly robust, it is largely a clinical 
perception that SSRIs (e.g., citalopram) are safe and 
efficacious in paediatric populations (DeVane and Sallee, 
1996; AACAP, 1998). The current off-label prescribing of 
the SSRIs for child and adolescent PTSD needs the support 
of blinded, systematic, placebo-controlled, efficacy and 
safety studies. In the interim, the current preliminary 
data do suggest continuity in treatment response to 
citalopram across adult and child/adolescent PTSD patients.  
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TABLE 1:  Demographic Variables and Characteristics of  
                     PTSD in Adolescents and Adults 
 
 
 
 
TOTAL SAMPLE 
(n = 38) 
ADOLESCENTS 
(n = 24) 
ADULTS 
(n = 14) 
 
Female (%) 
Mean age in years (SD) 
Mixed race (%) 
  
53 % 
21.34 (10.80) 
66 % 
 
54 % 
14.25 (2.31) 
83 % 
 
50 % ns 
33.50 (8.38) 
36 % 
 
Mean duration of PTSD 
symptoms in months (SD)  
 
Delayed onset of PTSD 
symptoms       (%)   
 
Multiple exposure to 
trauma  ≥ 3    (%)     
 
Index trauma (n) 
 
21.05 (34.07) 
 
 
 
29 % 
 
 
39 % 
 
10.96 (10.95) 
 
 
 
25 % 
 
 
33 % 
 
38.36 (50.80)ns 
 
 
 
36 % ns      
 
 
50 % ns 
Rape 16 12  4 
Witnessing violence   
or death    
 
 9 
 
 8 
 
 1 
Other sexual trauma  3  2  1 
Physical assault  6  1  5 
Torture  1  0  1 
Combat trauma  2  0  2 
Perpetration of 
violence 
 
 1 
 
 1 
 
 0 
ns no statistically significant difference between groups  
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TABLE 2: Comparative Efficacy of Citalopram in Adolescents 
and Adults                                                
 
RATING SCALE BASELINE WEEK 8 
WEEK 8 
Within–group 
differences 
(paired t-
tests) 
WEEK 8 
Between-
group 
difference
s 
(independe
nt 
t-tests) 
 
CAPS Total  
Adolescents  
Mean (s.d.)
 
79.8 (15.3)
Mean (s.d.) 
 
36.8 (26.1) 
 t      p 
 
 9.9   <.001* 
 df    p   
     Adults 79.9 (15.6) 48.9 (23.6)  6.4   <.001* 29.6  .165 
     
CAPS  
Re-experiencing 
 
 
  
 
 
 
     Adolescents 
  Adults 
 
CAPS  
Avoidance 
  Adolescents 
  Adults 
 
CAPS  
Hyperarousal 
  Adolescents 
  Adults 
 
CGI-Severity  
  Adolescents 
  Adults        
26.5 (5.9)  
19.6 (7.1)  
 
 
 
27.9 (6.8)  
29.9 (7.2)  
 
 
 
25.4 (6.1) 
30.4 (5.9) 
 
 
 4.9 (.65) 
 4.4 (.51)  
 9.7 (8.8)   
12.9 (8.0)   
 
 
 
15.9 (11.6)  
14.9 (9.9)   
 
 
 
10.9  (7.7)  
21.3  (8.2) 
 
 
 3.0  (1.1) 
 2.6  (.74) 
   9.1   <.001*    
 3.2   <.007*    
 
 
 
 6.1   <.001* 
 8.1   <.001* 
 
 
 
10.1   <.001*  
4.3     .001* 
 
 
8.2    <.001* 
8.3    <.001*  
                          
29.4  .259 
 
 
 
 
30.8  .792 
 
 
 
 
26.1  .001*
 
 
   
32.0 .845  
Intent- to-treat analysis with LOCF  
Adolescents: n = 24          Adults: n = 14 
  
*Represents significant differences within/ between samples  
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FIG. 1: CLINICIAN ADMINISTERED PTSD SCALE (CAPS) TOTAL 
SCORES (MEAN) AT BASELINE (WEEK 0) AND WEEKS 2, 4, 6, AND 8 
FOR ADOLESCENTS AND ADULTS 
 
 
 
 
 
No significant differences between groups at any of the 
time points 
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6. Conclusion & Directions for Future Research 
 
6.1 Summary  
The work presented here adds to existing evidence that 
adolescent PTSD is a common and chronic condition and that 
even in its subclinical form (partial PTSD), is associated 
with considerable morbidity. Adolescents with subclinical 
syndromes are as likely to demonstrate clinical impairment 
and distress as those with full-blown syndromes. The 
studies described in Parts 1 and II, although not 
conceptualised and designed to be directly comparative, 
nevertheless provide several convergent and replicable 
findings.  In comparing the South African school and clinic 
samples, perhaps most striking were the highly similar 
gender patterns of trauma exposure and full and partial 
PTSD that emerged. Male-female differences in the rates of 
trauma and PTSD (greater preponderance of PTSD in women 
despite the greater propensity for trauma [especially 
assaultive types] in men) that have so consistently been 
replicated in adult studies, did not hold true in these two 
adolescent samples. The results suggest that adolescent 
girls may be no more vulnerable than adolescent boys to the 
occurrence of major life traumas, with the exception of 
sexual assault. Nor were girls more likely to report 
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multiple events or more likely to be affected by the 
cumulative effects of multiple events than males.  
 
A second noteworthy finding, consistent across both 
samples, was that despite gender equivalence in the rates 
of full and partial PTSD syndromes, girls with full/partial 
PTSD were more likely to rate PTSD symptoms as occurring 
“most of the time” or “all of the time” than boys. Arguably 
the higher symptom burden in girls may to some extent 
account for the gender difference in functional impairment, 
with girls experiencing more interference from PTSD 
symptoms in family and social activities (but not in school 
activities), compared with boys. This suggests that, in 
assessing for gender differences in impairment in full and 
partial PTSD, it is also important to evaluate the impact 
of PTSD symptom frequency/ intensity on interference and 
distress. 
 
Partial PTSD, a concept that is not as yet accepted by the 
DSM-IV (APA, 2000), remains an under-researched nosological 
category, particularly in children and adolescents. In the 
DSM-IV, an inherent aspect of the definition of PTSD is the 
mandatory requirement of the clinical significance 
criterion, namely the presence of “clinically significant 
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distress or impairment in social, occupational, or other 
important areas of functioning”. This criterion is 
considered helpful for clinicians and researchers in 
establishing a threshold for diagnosis in those situations 
where PTSD symptoms on their own may not be pathological 
(APA, 2000).  However, many of the symptoms of PTSD (e.g., 
recurrent and intrusive distressing recollections, 
recurrent and intrusive dreams) are themselves pervasive 
and intrinsically distressing to children and adolescents, 
and almost invariably associated with some level of 
impairment. Focusing on impairment alone in this age 
group(where there is usually a reliance on parents and 
caregivers for information), may not be an entirely 
adequate means of making a valid distinction between full 
and subthreshold disorder (Spitzer and Wakefield, 1999). 
From a clinical viewpoint, it would seem reasonable to 
identify adolescents who satisfy the impairment/distress 
criterion, because they are the ones who are most likely to 
require intervention at some level. At this stage, much 
remains to be learnt about this form of PTSD: Is partial 
PTSD a distinct entity, is it PTSD that has not yet fully 
evolved, or is it perhaps PTSD that has gone into 
remission?  Replication of these findings in longitudinal 
studies may help to answer these questions and to 
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facilitate a better categorisation of PTSD phenomenology. 
It will be important to delineate whether subsyndromal 
forms in adolescents have the same biological underpinnings 
as full PTSD, through validation against neurobiological 
markers (e.g., cortisol) (Mylle and Maes, 2004). Of note, 
such a recent study in adults found that patients with 
persistent subsyndromal PTSD and marked hyperarousal had 
significantly elevated serum leptin levels (Liao et al., 
2004). Thus, leptin, a peptide hormone released from 
adipose tissue that regulates food intake and controls 
weight, may be a neuroendocrine marker for this form of 
PTSD in adults, but it remains to be seen whether this also 
holds true for adolescents.  
 
The high prevalence of multiple or compounded trauma 
exposure while not surprising, is concerning. It 
underscores the importance of routine and early detection 
of psychopathology in traumatised adolescents through 
informed, evidence-based assessment. In under-resourced 
settings, this is often difficult as many adolescents do 
not have access to mental health services. Moreover, many 
instances of adolescent injurious violence exposure remain 
hidden. The situation is aggravated by evidence from other 
countries which suggests that victimisation in adolescents 
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does not necessarily prompt use of health and trauma care 
services and that, in some instances, victimisation may 
actually be associated with a lower odds of subsequent 
mental health usage (Guterman et al., 2002). Nevertheless, 
routine enquiry of trauma in adolescents who present to 
general health care services may be the only way to enable 
timely referral and receipt of ameliorative treatment.  
 
As has been demonstrated here, the SSRIs may relieve 
intrusive, avoidance, and hyperarousal symptoms in 
adolescents, as well as treat comorbid conditions (e.g., 
depression) associated with serotonergic dysregulation. In 
fact, it has been suggested that SSRIs may more effectively 
reduce avoidant/numbing symptoms than other agents 
(Friedman et al., 1995). This fits well with the 
observation in both school and clinic samples of higher 
rates of avoidance symptoms among boys and girls, compared 
with symptoms from the other two symptom clusters.  
 
Recently there has much controversy about the use of the 
SSRIs to treat child and adolescent depression. Pooled 
analyses of 24 short-term placebo-controlled trials (4 to 
16 weeks) of nine antidepressant drugs (SSRIs and others) 
in children and adolescents with MDD, obsessive-compulsive 
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disorder, and other psychiatric disorders (involving more 
than 4,400 patients) revealed a greater risk of suicidality 
during the first few months of treatment, with an average 
risk of 4% for those on drug versus 2% for those on placebo 
(APA, 2004). No suicides occurred in these trials. Amidst 
conflicting data (and the issuing of a black-box warning by 
the FDA on all antidepressants distributed within the 
United States), there is indisputable evidence of the 
efficacy of these agents in treating adolescent depression, 
including suicidality. These data may also not be 
generalisable to the treatment of PTSD, and the 
consequences of not treating moderate to severe disorder in 
youth may pose a far greater risk to their normal 
development and future functioning. Nevertheless, 
physicians prescribing SSRIs and other antidepressant 
agents should be keenly aware of the presence of 
suicidality in their child and adolescent patients prior to 
and especially during the early treatment phase. The 
preliminary data presented here on the use of citalopram as 
a first-line treatment for adolescent PTSD suggests that it 
is safe (i.e., there were no instances of self-harm of 
suicidal ideation reported) and effective, and underscores 
the need to conduct research to clarify the potential value 
and risks of these agents for this disorder.  
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In addition to the need for well-controlled clinical trials 
of the SSRIs and other agents for child and adolescent 
PTSD, research on the effects of early interventions and 
treatments are sorely needed. To this end, longitudinal 
studies that identify adolescents who are at risk for 
developing PTSD and related symptoms by examining risk 
modifier variables (e.g., severity and duration of trauma, 
primacy of exposure, age [older vs. younger adolescents], 
gender, other life events, psychiatric morbidity, parental 
PTSD), taking into account developmental differences and 
social contextual factors (March, 2003), will likely 
provide information that is useful for initial and later 
treatment interventions. 
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